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Abstract
Research problem: Randomized controlled trials (RCTs) are essential; however, their
validity can be threatened through distortion or spin. This study quantifies publication bias
and distorted outcome reporting.

Methodology: All surgical RCTs registered on ClinicalTrials.gov from 1997-2017 were
identified and a sample was obtained through random and intentional selection. Failure to
publish (proportion of studies that remain unpublished), outcome distortion (changing
intended outcomes), and spin (distorted presentation) were explored. Comparisons were
made for positive versus negative studies and for high-income (HICs) versus low-middle
income countries (LMICs).

Results: In total, 13,761 RCTs were registered (median enrollment size = 96, 94% from
HICS). From a sample of 5,094 studies, 1,718 of them were published (34%). In total, 62%
of published conclusions declared a significant difference (1,058/1,718), of which 41%
(436/1,058) had “turned” positive due to spin or distortion.

Conclusion: While a large volume of RCTs have been registered, many remain unpublished.
High proportions of spin and distortion raises concerns for validity of the evidence base.
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Summary for Lay Audience
Randomized controlled trials (RCTs) are a necessary tool to support evidence-based
decision making in clinical practice. To provide valid information, it is essential that RCTs
publish all their results and report the outcomes without bias. In this study, we examine
characteristics and trends of surgical RCTs including evidence of publication rates and
outcome distortion. To do this, we retrieved all surgical RCTs registered on
ClinicalTrials.gov between 1997 and 2017. We examined the research base describing the
global spread of studies and volume of study registration across the years. After this, we took
a sample of the studies to search for publication and compared the outcomes that were
intended to be reported with the outcomes the publication reported. Differences between
intended outcomes and reported outcomes are known as outcome distortion, and
misrepresentation of results in the presentation of the outcomes is known as spin. These
characteristics were compared between positive and negative studies, as well as for highincome countries (HIC) and low-middle income countries (LMIC). In total, we retrieved
13,761 RCTs that met the inclusion criteria. These studies had a median enrollment size of
96 that decreased across the years, and mainly pertained to HICs (94%). The number of
studies registered each year was increasing; however, the proportion labelled “Completed”
was decreasing. The sample of studies consisted of 5,094, where 1,718 were published
(34%). Of published studies, conclusions with significant differences were declared in 62%
of the studies (1,058/1,718), of which 41% (436/1,058) turned positive due to spin or
distortions of outcomes. HIC had a higher failure to publish rate than LMIC (63% vs. 49%
unpublished), but overall had more studies published, and increasing proportion of positive
studies published. The high proportion of studies in HIC is a concern for global
generalization and should be more reflective of where majority of the world’s population lies.
Additional concerns for research integrity and validity of the evidence base lie within the
large proportion of unpublished studies (66%) despite the large volume of registered studies.
In order to ensure adequate decision making, further efforts to ensure publications are
conducted without biases are necessary.
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Chapter 1

1

Literature Review & Introduction

1.1 Surgery
Derived from the Latin and Greek words for “hand work”, the term surgery is
defined as the treatment of injuries or diseases in people or animals by cutting open the
body and removing or repairing the damaged part.1,2 Though definitions vary across
dictionaries, the commonalities are that surgery is a procedure to cure or treat the burden
of disease using techniques related to cutting the body open.1 This procedure is relevant
for any and all body parts such as Gastroenterology, Ophthalmology, Otolaryngology and
Cardiology to name a few. The term “surgery” can also be referred to as an operation, a
surgical procedure, and other specific terms more specific to the area of the body such as
an appendectomy referring to the removal of the appendix, or a cesarean section referring
to childbirth through an incision of the abdomen. While the field of surgery itself has
evolved extensively, the role of the surgeon has adjacently evolved, moving from a
largely technical role focused on performing the operation, to a position of both
technician and doctor managing the diseases within and beyond the operating room.3

Throughout history, advancements in technology and medicine have driven the
evolution of surgery, predominantly as a result of the technology boom of the last 200
years.1 Although humans have been performing surgeries for centuries with the first
known record of surgery to be in 600 B.C, it wasn’t until the “Industrial age” of the mid1800s and the introduction of new instrumentation and anesthesia that the field of surgery
really started to develop.1,2 Following this age, technology and medicine continued to
grow coming into the “Information Age” of the 1950s.1 This allowed for more invasive
open techniques as a result of the discovery of antibiotics and the utilization of
intravenous fluids, and eventually video cameras, robotic systems, and thus, minimally
invasive procedures that revolutionized surgery as a whole.1
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1.1.1

Access to Safe Surgery
According to a World Health Organization (WHO) modelling study performed in

2008, there are an estimated 234.2 (95% CI 187.2–281.2) million major surgeries
performed each year worldwide.4 Of this 234.2 million, a disproportionate 73.6% were
estimated to occur in high or middle-income countries, while only 30.2% of the world’s
population resides in these locations.4 The risk of death and complications associated
with surgery has lessened through time; however, there is still an estimated permanent
disability or death rate of 0.5-0.8% after major surgery in high-income countries, and the
risk remains several-fold higher in low-middle income countries for procedure-matched
and risk-adjusted comparisons.4 Surgical complications occur in up to 25% of patients,
with at least half of them considered to be avertable.5 Simultaneously, there is a close
correlation (R2=0.996) between per-capita expenditure on health and the volume of
surgery.4 It is now estimated that 16.9 million lives are lost every year due a lack of
access to surgical care, indicating an urgent need for proportionate and increased surgical
care available, particularly in resource-restricted countries.6

1.2 Randomized Controlled Trials
Randomized controlled trials (RCTs) are a type of experimental study, where
participants are prospectively randomized to either intervention or control group, to
(theoretically) ensure groups are comparable for all aspects other than the difference
provided by the intervention under study.7 The RCT is often referred to as the gold
standard for ascertaining efficacy and safety of an intervention, allowing for reduced
confounding and improved measurement of intervention effectiveness while reducing
bias through the randomization process.7 In the hierarchy of evidence to inform decisions
about what works, well-conducted randomized trials (or systematic reviews of all
relevant randomized trials) remain at the top of the hierarchy in terms of evidence
validity.8 Randomized allocation is often done using automated randomization tools such
as computerized random number generation to ensure allocation is beyond the influence
of investigator. In addition, allocation of the participants is ideally blinded to the
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participants, researchers, and the medical professionals applying the interventions in
order to minimize threats to randomized allocation.7 However, in the field of surgery,
blinding of patients, clinicians and investigators is particularly challenging since surgery
is a procedure which is difficult to emulate with a “placebo” or matching “sham” control
in a manner that reliably hides knowledge of which intervention was received. If the trial
addresses a surgical intervention compared to non-surgery, it can be challenging to
conceal if a surgery has taken place due to the invasive nature of them, and ethical
concerns may arise in proposing sham surgeries. Additionally, despite being the gold
standard of clinical research, RCTs may have other drawbacks including high resource
demands, and threats to validity if there is attrition during longer term follow up.
Furthermore, barriers to recruitment may result in a population that is less generalizable.8
As the highest level of evidence, performing RCTs are the ideal for all areas of research
and undoubtedly in surgical research due to the invasive nature and high risk of harm,
warranting a need for high quality evidence-based research.
A total of 386,745 studies from 219 different countries have been registered
between 1997 to the present day (August 15, 2021), and approximately half of these are
randomized trials.9 The number of studies registered has increased over time, possibly
due to increased mandates for registering. In 1997, there were only 323 registered
randomized trials, whereas in 2020 there were 14,313. Registrations in 2021 will soon
exceed those in 2020 since there have already been 13,025 by mid-August 2021.

1.3 Trial Registration
As of September 2005, The International Committee of Medical Journal Editors
(ICMJE) has defined a list of 6 web-based registries without for-profit affiliations
considered acceptable for trial registration : www.anzctr.org.au, www.clinicaltrials.gov,
www.ISRCTN.org, www.umin.ac.jp/ctr/index/htm, www.trialregister.nl and
https://eudract.ema.europa.eu/.10 Additionally, any registries within the WHO
International Clinical Trials Portal will also be accepted.10 For our research, we selected
ClinicalTrials.gov since it is has been the most commonly used registry over the past 20
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years, spanning 219 countries worldwide and receiving about 4.5 million visitors each
month.8 It is a well-established resource, featuring both publicly and privately funded
projects, that is intended for providing a public platform for patients, researchers, health
care professionals, and the general public to view registered, ongoing, and completed
clinical trials.11 Due to the public nature of the site, researchers can be held accountable
for maintaining the intentions of their trial consistent, and transparently reporting any
changes to the original plan. Trial registration is intended as one safeguard to up-hold
transparency and integrity of research, and theoretically should aid in the reduction of the
net adverse effects of reporting bias, publication bias, and spin on the evidence base.
Trial registration also contributes to other benefits including redundant duplication of
clinical trials and unnecessary research waste. A further benefit may include opportunity
for patients and investigators to publicly access recruiting studies to see if they qualify for
enrollment. Lastly, clinical trial registries may facilitate ethics review boards and
granting agencies to make decisions about new proposed clinical trials.10

According to the Food and Drug Administration Amendments Act (FDAAA) that
governs ClinicalTrials.gov, all studies that are controlled clinical investigations of any
drug, biological product, or medical device, excluding feasibility trials, and are initiated
either after September 27, 2007, or prior to and still ongoing past December 26, 2007,
must be registered (exceptions and further details can be reviewed within the FDAAA
801 document).12 The ICMJE follows similar guidelines for trials to be eligible for
publication in one of their journals.10 They state that trials beginning on September 13,
2005 or later for any intervention will be considered for publication in an ICMJE journal
only if they are registered in one of the accepted registries and contain all the information
within their registration (exceptions and further details can be reviewed within the ICMJE
information pages).10 A typical trial registration will define participant enrolment criteria,
condition or disease, intervention and comparators, primary and secondary outcomes,
study locations along with contact information, and other relevant information.11
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1.4 Research Integrity Within Publications
1.4.1

Pressure to Publish
Within the academic community, there is an immense pressure to produce a high

volume of publications, or highly cited publications as these are rewarded by current
evaluation frameworks for promotion and tenure.13 Research publication remains one of
the most highly valued measures of academic success, potentially lead to increased
funding for the institution and an overall increased status of the institution on the global
stage.13 This incentivized structure has contributed to the increase in research publications
over the years. A 2014 study from Cornell University examining global volume of
scientific publications on the Web of Science (WoS) database showed an exponential
growth between 1980 to 2012.14 They claim that in the mid-1700s the growth rate was
less than 1%, increasing to 2-3% by the mid-1900s, and then increasing to 8-9% by
2012.14 Though the study also claims that these values are likely incomplete, potentially
overestimating the growth rate due to the difficulty of tracking studies from the earlier
years, there is clearly an exponential growth of published scientific literature in recent
decades.14

The pressure to publish has been a contributor to unethical research practices,
breaching research integrity, and increasing overall wasteful research.13 It has been stated
that only 42% successfully published articles receive more than 1 citation, some of which
are self-citations from the authors or journals (5-25%).13 Additionally, less than half
(45%) of the articles published in the top 4500 scientific journals receive a single citation
within the first 5 years of publication.13 This suggests that much of the published work
goes unnoticed, and may fail to meaningfully contribute to the chain of knowledge
translation and evidence-informed decision making.13

1.4.2

Spin
For patients to receive the best possible care, it is vital that the research pool is

continuously updated, and the best practices are in use. With the pressure to publish,
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some researchers may be incentivized to adopt questionable or unethical practices to
increase likelihood of publication.13 Questionable or unethical practices may range from
more nuanced practices such as selective reporting of positive or “more interesting”
results, switching non-significant originally planned primary outcomes with significant
secondary outcomes, failing to publish study results, over-interpreting results to align
with preferred conclusions, indiscriminate statistical analysis to ‘find’ significant
outcomes, non-transparent declaration of statistical plan or changes to original protocol,
all the way to potential extreme of overtly nefarious practices such as falsification of
results, fraudulent data manipulation. In effect, anything that researchers do either
subconsciously or consciously to collect or interpret data in ways that misrepresent the
original intentions of the research, or selective reporting favourable results, leads to
questionable research outcomes.13
This misrepresentation of research is commonly known as “spin”, and involves
the deceptive use of presentation or language to display results that emphasize the
benefits of favourable results or mask unfavourable results, despite a non-statistically
significant outcome.15 Spin tactics can be used to either alter the outcome completely, or
simply mislead the reader with the choice of wording or display of the results.15 A study
by Boutron and colleagues analyzed the extent of spin in published RCTs with nonsignificant primary outcomes, where spin was defined as: a “specific reporting strategy”
involving result misrepresentation that can “highlight that the experimental treatment is
beneficial, despite a statistically nonsignificant difference for the primary outcome, or to
distract the reader from statistically nonsignificant results”.15 They identified spin within
results and conclusions sections in 27% of published study abstracts, and in 42% of the
main manuscripts.15 The act of spinning research results can be either conscious or
subconscious; however, regardless of the specific intention or motive, the far-reaching
health and social consequences of spin on interpreting the evidence base should not be
minimized. It is essential that researcher education, awareness, and skills be increased to
recognize and mitigate spin. Additionally, meta-researchers should evaluate the current
evidence base to quantify spin more transparently, and highlight inconsistencies between
the planned research, reported, results, and interpretation of findings.15
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Spin can be present in many ways. Commonly, spin is incurred through
misleading language such as using causal language to infer beyond what the results have
shown. Another common approach is for spin to be incurred through distraction from
non-significant or non-favourable results, often with a focus on other secondary
statistically significant results cherry-picked from a long list of potential outcomes that
increase risk of false positives with indiscriminate use of analytic flexibility, also known
as ‘researcher degrees of freedom’ and the ‘garden of forking paths’.16 A number of
techniques used by researchers may be used consciously or subconsciously to deflect
attention from non-significant results to ‘turn’ the story toward statistically significant
results, including focusing on secondary outcomes or subgroup analyses, interpreting
statistically non-significant results in a manner suggesting at equivalence between the
interventions, or eliminating or downplaying adverse events while placing emphasis on
the positive or beneficial results.16 Spin can ultimately be present in any section of the
research publication, from the title to the conclusion; however, it is predominantly
present in places where there is an opportunity to interpret results, such as in the title,
discussion, and the conclusion sections.16 Research that is published or presented with
spin is an inaccurate representation of the results, and leads to detrimental impacts on
health and society through misguided decisions and harm to patients and society at
large.16

1.4.3

Outcome Distortion
Outcome distortion is related to the concept of spin; however, instead of

misrepresentation of outcomes through highlighting significant results or distracting the
reader from non-significant results often through the use of language, outcome distortion
refers to the selective reporting of numerical outcomes through swapping non-significant
outcomes with significant ones or removing non-significant outcomes as a whole.15,17
Generally this is seen as the omission of non-significant outcomes referred to as selective
reporting or switching a primary outcome that is non-significant with a secondary
outcome that is significant to present positive results though these were not the originally
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intended outcomes.17 For example, this can include the omission of a negative result, but
it can also include the omission of an analysis such as an adjusted analysis or intentionto-treat if it does not agree with the rest of the results. In this case, a positive result is one
where a statistical difference is seen between the intervention groups, where a negative
result is where a null result is observed usually without statistical significance. 18 While
positive results may seem interesting or are said to be favourable for publication, nonsignificant results are equally as important for the evidence base. A 2010 study reported
that when comparing published medical studies to their protocols, about 40-60% of them
had introduced, omitted or the changed primary outcomes from the per-protocol
intentions.19 Outcome distortion in research can lead to overestimating the positive
results, lack of transparency for all the available evidence, and leads to concerns of
validity of clinical trials.

1.4.4

Publication Bias and Failure to Publish
There is a common perception, and some analyses have shown, that studies with

positive findings have a greater likelihood of being published in a higher-impact journal,
and at quicker rates.18 Ideally, published results will be transparently reported as intended
per-protocol despite the directionality of results. However, in a number of cases, spin and
outcome distortion are used by investigators to create positive results for publication.18 A
2014 study provides an overview of empirical evidence for this belief, including “timelag bias”, where negative studies are published with a greater delay, and the “proteus
phenomenon” suggesting that delayed negative publications contradict the positive
findings creating extreme contradictions in the evidence base.17 Another 2013 study
examining publication rate for drug related clinical trials in Spain found a publication rate
of 84.9% (180/212) for studies that concluded positive results, and 68.9% (128/186) for
negatively concluded studies. The study also reported that positive studies had a median
time to publication of 2.09 years compared to 3.21 years, suggesting a potential impact of
positive studies. Negative trials will often be disregarded or never submitted to journals,
which leads to the “file drawer problem” of failing to publish. Together, these biases lead
to overrepresentation of positive results in the evidence base.18 With only a subset of the
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evidence available to the public, formulation of false conclusions and distortion of metaanalyses may ensue, resulting in unnecessarily repeated future work and wasted research
opportunities and resources.20

1.5 Rationale
Randomized controlled trials (RCTs) are an integral aspect of evidence-based
medicine and are especially important to guide decision making in high stakes areas such
as surgical care. However, without research integrity and full transparency within the
literature, inadequately performed and reported RCTs can jeopardize the validity of the
evidence and threaten decision making. Similarly, it is necessary for research to be
relevant and generalizable to the global population where it will be used. This integrated
thesis consists of 5 chapters, the first chapter providing background information and
rationale for this topic, the three middle chapters each building on the prior chapter to
characterize the state of the evidence in the field of surgery, with a focus on degree of
outcome distortion and spin in registered RCTs over the past two decades, and the final
chapter providing an integrated discussion and future directions.

Chapter 2 will describe characteristics of the entire volume of surgical RCTs
registered on ClinicalTrials.gov between 1997-2017, with a focus on the distribution of
research production globally, rate of study registration and completion over the years,
enrolment size, surgical category, and other basic characteristics. This will provide us
with a valuable understanding of the types of procedures of focus, sample size, and where
majority of the studies are being produced, and if this is proportionate with where most of
the world’s population resides. Additionally, we will be able to view trends of study
registration over time, and if completion rate is following the same trend. This knowledge
will uncover where the gaps in the literature are, and where we need to direct future
research.

To analyze research integrity, Chapter 3 will obtain a sample of the full cohort of
studies identified in Chapter 2. Using this sample, we will search for published studies to
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compare intentions set by the registries to the outcomes that were reported in the studies.
Searching for publications will provide us information on the publication rate of studies
and identify the proportion of studies that failed to publish. Within the published studies,
we will be able to compare the proportion of studies that achieved a positive overall
result against a negative overall result and analyze which of these studies kept their
intentions from the registries and which turned positive, potentially in the search for an
interesting conclusion. Retrieving the proportion of positive studies and the studies that
turned positive will reveal the level of distortion, spin and ultimately research integrity
held by the evidence base and offer areas where improvement in research reporting may
be necessary.

Using the same sample, Chapter 4 will address the same areas for research
integrity to explore differences between high-income settings (HICs) versus low-middle
income settings (LMICs). Study characteristics, outcome distortion, and spin will be
compared for HIC and LMICs. Chapter 2 identified distributions of study registration
globally, and now in Chapter 4, we will determine whether rates of publication, outcome
distortion, and spin are related to income level of country in which the study was
conducted. We will also compare basic characteristics between these groups to see if
there is a difference in the studies produced in differing income levels. The aspirational
global goal in research should be to produce studies proportionate to where the world’s
population resides, relevant to burden of disease regardless of income level of the
country, so we hope to determine if this is the case.

Together, these chapters will address the questions: What is the state of the
evidence base in the field of surgical RCTs? To what degree is registered research
completed and published? And of the published research, to what degree is distortion and
spin detectable in the results? Altogether, this integrated research will help to inform the
integrity of the current evidence base in surgery, and will provide insight for researchers,
physicians, and policymakers for future improvement.
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Chapter 2
Characterizing the Global Body of Registered Surgical
Randomized Controlled Trials from 1997 to 2017

2

A large volume of surgical randomized controlled trials (RCTs) has been
registered in ClinicalTrials.gov over the several years, with an increasing amount
registered each year. Understanding the characteristics and distributions of the global
surgical research is valuable knowledge to understand the gaps that may lie regarding
generalizability or applicability of the research, and where further research should focus.
The objective of this chapter was to characterize the registered surgical research and
identify gaps or disproportions that can be described on a global scale.

2.1 Introduction
Many barriers exist to performing a high-quality study at low risk of bias in the
field of surgery. The high level of risk involved with surgery demands a high burden of
proof for safety and efficacy, yet surgical trials are particularly difficult to perform since
surgical procedures are more involved with added challenges to randomization, blinding
and informed consent compared to studies of more simplistic interventions such as drug
therapies.21, 22 To understand the global state of the evidence base related to surgery, it is
necessary to evaluate the volume of this research on a global scale to uncover where the
inequalities lie and what the trends are over time. More specifically, there is a
disproportionate representation of high-income to low-income countries producing the
research where tackling these gaps in information will lend to a more equal distribution
of research production and in turn limit the bias across economic settings. With this, we
will obtain an understanding of characteristics of the studies, changes over time, and thus
will have a valuable perspective for the integrity of the research conducted. To our
understanding, there has not been a review for the entirety of the surgical research base
spanning over 2 decades thus able to analyze the trends and potential changes in the
characteristics of the studies over the years. With this said, we aim to describe and
characterize the global research trends on human surgical procedures that have been
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registered on ClinicalTrials.gov from 1997 to 2017 and identify any gaps or
disproportionate representation within the research base.

2.2 Methodology
2.2.1 Search Strategy
A search strategy was formulated to capture all randomized studies that involved
a surgical procedure on humans registered on ClinicalTrials.gov database between
January 1, 1997, to December 31, 2017. Established in 1997, ClinicalTrials.gov is a
database of registered clinical trials for both privately and federally funded studies from
219 countries.3,4 Initially, all studies up to the end of 2020 were captured in order to
identify an appropriate end date. After finding that the median completion time for
studies reported on the registry was just over 2 years (25 months), it was estimated that
allowing 3+ years for study completion was considered sufficient to capture an accurate
and large volume of studies. Consequently, we chose end of 2017 as the end date of our
study to allow for sufficient time elapse between trial registration, trial completion, and
publication.

The search was conducted in November 2020 using the Expert Search feature in
ClinicalTrials.gov and included an exhaustive list of terms describing variations of
“surgery”, as well as the different types of specific procedures (i.e., caesarean,
appendectomy, rhinoplasty, etc.). To ensure that we captured studies that had randomized
allocations, the list of search terms was joined with iterations of the term “randomized”
using the Boolean operator “AND”. The surgical terms were searched within the title, the
brief summary, and the designated intervention section of the registry, while the
randomized terms were searched within the title and the design allocation sections.
Additional restrictions were placed to limit the study type to “interventional” in order to
help identify randomized studies, and for dates to fall within the designated date ranges.
The exact search strategy used for the search is included in Appendix 1.
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2.2.2 Screening for Inclusion
After extracting the studies from ClinicalTrials.gov, they were screened according
to a predefined inclusion criterion: the studies must be a randomized allocation design
with human patients undergoing a surgical procedure. A surgical procedure is defined as
an incision made using a cutting tool while undergoing either local or general anesthesia.
The screening was done by one reviewer who examined the pre-extracted pieces of
information from ClinicalTrials.gov including the title, interventions, and the arms of the
interventions. If it was still unclear whether the trial met the inclusion criterion from
these characteristics, the registry was further examined using all other available
information. Screening was conducted between November 2020 and January 2021.

2.2.3 Data Extraction
Study characteristics were extracted from the included registered studies,
including enrollment size, date of registration, date of study completion, country where
the study was performed, status of the study (completed, recruiting, not yet recruiting,
enrolling by invitation, active not recruiting, suspended, terminated, withdrawn, and
unknown), intervention type, and outcome measures. It was assumed that the registries
were updated by the authors and correctly inputted, so we directly used the registry for
information unless it was unavailable. While most of the registered studies provided the
necessary characteristics, some did not have this explicitly listed in the proper section of
the registry. Therefore, a custom Python program that matched key words of the data
extracted characteristics to sections within the registry (Appendix 5) was used to retrieve
information from other sections of the registry. In addition, published articles were also
sought to inform missing fields when possible. We ended the data extraction process in
April 2021.

2.2.3.1 Completion Status and Time to Completion
Completion status was defined as “Completed”, “Not Completed”, or “Ongoing”
based on the following categories given in ClinicalTrials.gov: “completed” consisted of
studies with a ‘completed status’; “not completed” consisted of ‘suspended’,
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‘terminated’, ‘withdrawn’, or ‘unknown’ (which includes trials not updated past the
recruitment phase, and the status has not been verified within 2 years and the estimated
completion date has passed); and “ongoing” consisted of registered studies in the
recruitment phase including ‘not yet recruiting’, ‘recruiting’, ‘enrolling by invitation’,
‘active’, or ‘not recruiting’. For the completed studies, time to completion was also
calculated by taking the difference between the start and end date published in the
registry.

2.2.3.2 Human Development Index and Geographic Region
The country of study conducts, and the respective Human Development Index
(HDI) was recorded. In the case that the country was not available from the registry, we
attempted to look for the country in the study publication if the publication was available.
These countries were then grouped according to the HDI and geographical region. The
HDI was obtained from the United Nations 2019 report.23 If a study involved multiple
countries, the average of the countries’ HDI was taken. Countries that did not have HDI
available (i.e., countries that no longer exist) were matched with the country that they
now belonged with or an average of analogous countries. Along with the HDI, the studies
were placed into the universally accepted categories of very high, high, medium, or low
HDI.23 In addition, we categorized the countries where the trials were conducted
according to geographic regions designated by the World Health Organization (WHO).24
These regions include the African Region, the Region of the Americas, the South-East
Asian Region, the European Region, the Eastern Mediterranean Region, and the Western
Pacific Region. Countries not listed as a part of the WHO regions were placed into
categories based on their geographic location.

2.2.3.3 Surgical Categories
For each registered trial, type of surgical procedure performed was extracted from
ClinicalTrials.gov according to the following surgical categories: Breast; Orthopedic;
Neurology; Transplant; Obstetrics and Gynecology; Plastic; Urology; Pediatric; Cardiac,
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Vascular and Thoracic; Otolaryngology; Thyroid; Dental, Oral and Maxillofacial; Colon
and Rectal Surgery; Ophthalmic Surgery; Gastroenterology; and General.

2.2.4 Statistical Analysis
Summary statistics (frequencies and proportions) were calculated using
Microsoft® Excel (v.16.51), including number of studies reaching completion, the
proportion of completed studies, and the average sample sizes for all registered surgical
clinical trials by creating various charts using Microsoft® Excel. To visualize the
number of studies registered and the relative HDI categories for the countries of
registration, a world map was created in Tableau Desktop v.2021.1.5
(20211.21.0819.1914), wherein each country is represented by a bubble, where size of
the bubble represents the number of studies registered there, and colour of the bubble
represents the HDI level.

2.3 Results
2.3.1 Search Results
Between the beginning of 1997 and end of 2017, a total of 264,301 studies were
registered in ClinicalTrials.gov. Of these, 209,209 (79.2%) were labelled as
“interventional”, and limiting it further, 138,593 (52.4%) were randomized. Searching by
our list of terms (Appendix 1) yielded 24,740 (9.4%) surgical RCTs to be screened for
inclusion. Of these, 13,761 RCTs met the inclusion criteria, representing 5.2% of all
studies registered between 1997 and 2017. Baseline characteristics of the trials are shown
in Table 1.
Table 1: Characteristics of Registered Surgical RCTs (1997-2017)
Characteristic
All studies (n=13,761)
No. (%)
Location by Region
Americas

5,931 (34.3)

Europe

7,568 (43.8)

16

Western Pacific

2,545 (14.7)

Eastern Mediterranean

753 (4.4)

South-East Asia

362 (2.1)

Africa

128 (0.7)

HDI1 Category
Very High

10,567 (76.8)

High

2,378 (17.3)

Medium

184 (1.3)

Low

35 (0.3)

Surgical Category
Breast

380 (2.8)

Orthopedic

2,745 (20.0)

Neurology

308 (2.2)

Transplant

738 (5.4)

Obstetrics and Gynecology

1,318 (9.6)

Plastic

256 (1.9)

Urology

713 (5.2)

Pediatric

482 (3.5)

Cardiac, Vascular and Thoracic

2,198 (16.0)

Otolaryngology

312 (2.3)

Thyroid

121 (0.9)

Dental, Oral and Maxillofacial

443 (3.2)

Colon and Rectal Surgery

754 (5.5)

Ophthalmic Surgery

582 (4.2)

Gastroenterology

1,939 (14.1)

General

471 (3.4)

Completion Status
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Completed

7,849 (57.0)

Not Completed

4,307 (31.3)

Ongoing

1,605 (11.7)

Enrollment Size, median (IQR)

96 (52–195)

Enrollment Size, mean (range)

256(1-19,000)

Time to completion (months), median (IQR)

25 (14–45)

Time to completion (months), mean (range)

34 (0-246)

1. HDI = Human Development Index

2.3.2 Human Development Index and Geographic Region
The majority of surgical RCTs were performed in countries with a very high or
high Human Development Index (HDI). Together, studies that took place in very high
(76.8%) and high (17.3%) HDI countries made up 94.1% of the total number of studies
that met the inclusion criteria, leaving studies from countries with medium HDI with
1.3% and low HDI with 0.3% (Table 1). When observing the studies by year, we notice
that the first medium-HDI study does not appear until 2001, and the first low-HDI study
does not appear until 2007, but the number of studies from both HDI categories has
slowly increased over the subsequent years until 2017 (our study end date) (Table 2). A
table of the number of studies, HDI value, HDI category, and geographic region for each
country can be found in Appendix 3.
For geographic regions, the European Region had the greatest percentage of
studies with 43.8%, followed by the Region of the Americas with 34.3%. Very little
representation was seen from the Africa Region (0.7%), the South-East Asian Region
(2.1%) and the East Mediterranean Region (4.4%) (Table 1). At a country level, the
largest proportion of studies came from the United States taking part in 23.3% of the
studies.
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Table 2: HDI Categories and Enrollment Sizes Distributed by Year
Year

Enrollment Size

HDI Categories (No.)

(mean)

Very high

High

Medium

Low

1997

27

2

0

0

286.9

1998

50

0

0

0

467.4

1999

46

6

0

0

541.4

2000

61

6

0

0

354.8

2001

110

2

1

0

346.3

2002

139

10

0

0

327.8

2003

186

10

3

0

304.8

2004

260

18

3

0

320.4

2005

341

30

5

0

197.9

2006

400

39

4

0

274.0

2007

482

55

9

1

235.8

2008

616

99

4

2

211.6

2009

678

87

16

2

156.4

2010

724

126

8

2

158.4

2011

858

156

16

7

150.9

2012

806

140

6

4

174.8

2013

886

189

15

3

175.4

2014

928

275

11

2

164.4

2015

964

294

18

4

182.1

2016

977

401

36

4

160.2

2017

1,060

440

29

4

187.1
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2.3.3 Completion Status

Figure 1: Percentage of studies completed by year of study registration

Figure 2: Number of studies according to completion status by year of study
registration
The number of surgical RCTs registered each year increases as the years progress
(Figure 1), while the proportion completed decreases notably over the years. In total, 57%
of registered surgical RCTs were labelled “Completed”. In the inaugural year of the

20

database, most of the studies that were registered on ClinicalTrials.gov were labelled as
“Completed” (83.9%), whereas the percent of completed studies drop by more than half
in 2017 with only 39.0% of the studies completed (Figure 2). As expected, the number of
ongoing trials increases in more recent years (Figure 1). Time to completion averaged 34
months and had a median of 25 months. The higher mean time to completion compared
to the median suggests at a positive skew where more studies will fall to the lower end of
the time to completion.

2.3.4 Enrollment Size

Number of Studies Registered

1200.00

900.00

120
Not Completed

600.00

Completed
300.00

0.00

621
-300.00
1995

2000

2005

2010

2015

2020

Year of Registration

Figure 3: Average enrollment sizes indicated by the size of the bubbles and number of
registered studies from 1997 to 2017
The median enrollment size across all studies was 96 (IQR 52–195), and the mean
was 256 (Table 2). As seen by the decreasing size of the bubbles in the later years,
enrollment size has decreased over time while number of registered studies has increased
(Figure 3). The overall maximum average enrollment size was seen in 1999 with an
average of 541 and the minimum was seen in 2011 with an average of 151. Comparing
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enrollment sizes between "Completed” studies and "Not Completed” studies (which
includes "Ongoing” studies), the trends of average enrollment sizes remain similar. The
highest average enrollment is seen in 1997 for “Not Completed” studies with an average
of 621 and the lowest is seen in 2017 for “Completed” studies with an average of 120.
The size of the bubbles for completed studies are generally smaller compared to the
bubbles for the "Not Completed” studies, especially in the later years, showing smaller
enrollment sizes in completed studies as the years progress.

2.3.5 Surgical Categories
350
Orthopedic
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Gastroenterology
Cardiothoracic

NUmber of Studies
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Breast

100
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Otolaryngology
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Ophthalmology
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Year of Registration
Figure 4: Surgical categories from 1997 to 2017
Regarding the distribution of surgical categories, the four most common
categories are Orthopedics (20.0%), Cardiac, Vascular and Thoracic (16.0%),
Gastroenterology (14.1%), and Obstetrics and Gynecology (9.6%) (Table 1) (Figure 4).
These 4 categories also increase at a faster rate over the years than the others (Figure 4).
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It was not until 2003, 6 years into the data, that all the surgical categories were present.
Prior to that, at least 1 surgical category was not represented in the data each year. A list
of specific surgical procedures and their corresponding surgical categories can be found
in Appendix 4.

2.3.6 Geographic Distribution of Registered Surgical RCTs

Figure 5: Number of surgical RCTs registered according to country Human
Development Index.
The size of the bubbles indicates the number of studies, while the colour of the
bubbles indicates the HDI of the country, where the dark red to dark blue colour
gradient represents low to very high HDI countries, respectively.
In Figure 5, the geographic distribution and HDI status indicates that most
registered studies took place in very high-income countries. Studies from high HDI had
larger enrollment sizes compared to registered studies from low-income countries. In
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total, 76.8% of registered surgical RCTs were from very high-income countries, mostly
in North America, Europe, and some parts of Asia. In contrast, only 0.3% of registered
surgical RCTs were from low-income countries.

2.4 Discussion
In total, 13,761 surgical RCTs were registered in ClinicalTrials.gov between 1997
to 2017, with a median enrolment size of 96. While the number of surgical RCTs
registered per year has increased over the past 20 years, the average enrolment size has
decreased. A total of 43% of studies did not reach completion, with an increasing trend of
non-completion over the past 20 years. For studies that reached completion, the median
time to completion was 25 months (mean: 34 months). The surgical specialties most
commonly addressed in registered RCTs included orthopedics (20%), gastroenterology
(14%), cardiac, vascular, and thoracic (16%), and obstetrics and gynecology (9.6%).
More than 94% of studies are from high-income countries (very high and high HDI), and
very few studies are from lower income settings where the majority of the world
population resides.

This analysis provides implications for relevance and integrity of the surgical
evidence base and provides areas for future improvement. While it is positive that there is
a relatively large number of registered surgical RCTs, a significant portion remain
incomplete, and this gap between registered and completed seems to be expanding as the
years progress. Proportion of completed studies has been decreasing across the years, and
especially after 2013. To some degree, this is expected as there is less time in recent years
for registered trials to reach completion status; however, we tried to minimize this impact
given the median time to completion was about 2 years (25 months). This raises the
question, what is the barrier to hinder these studies from completion? Future studies
should explore the barriers and facilitators to study completion.17

The proportion of studies belonging to areas with a very high HDI also
contributes to concerns regarding generalizability and applicability of the evidence base.
Registered studies from medium and low HDI countries first appear in 2001 and 2007,
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respectively, (each focused on Obstetrics and Gynecology surgery). The combined
proportion of 1.6% of registered RCTs from low- and middle-income countries shows
clear lack of proportional representation across the HDI categories. Although this is
evidently a generalizability issue, it is congruent with the challenges encountered in these
settings where there is reduced surgical volume per capita and limited access to surgical
and research infrastructure.

Table 3: Distribution of registered surgical RCTs by HDI category compared to
world population
HDI Category
World Population25
Registered Surgical RCTs
Very High

19.9%

76.8%

High

37.4%

17.3%

Medium

29.9%

1.3%

Low

12.8%

0.3%

The lack of representation from countries with medium and low HDI, and those
located in regions other than Europe and the Americas is evident, with an overwhelming
percentage in very high HDI settings (76.8%). According to 2020 data from the World
Population Review, only 19.9% of the world’s population lives in countries with a very
high HDI, whereas 37.4% live in high, 29.9% live in medium, and 12.8% live in low HDI
countries.25 The ratios of where the majority of the world population lies is not
proportional to where most of the studies are being conducted (Table 3). The global
burden of diseases and conditions warranting surgery is not met and necessities of types
of surgeries and proportions for populational burdens is unbalanced.32 The
disproportionality of involved countries and respective HDIs provides urgency for study
conduct in regions where most of the world’s population matches that disease burden.

Average enrollment sizes were seen to decrease over the years, along with smaller
enrollment sizes in “Completed” studies in comparison to “Not Completed” studies.
Several explanations could be used to describe this trend, providing explanation as to
why the decrease in enrollment sizes is not a major concern, while the discrepancy
between sizes for “Completed” and “Not Completed” remains to be an issue of integrity.
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Questions arise around why the completed studies are smaller, and whether they are
smaller than their intended enrollment sizes on ClinicalTrials.gov, which was beyond the
remit of this study to explore. Regarding the overall decrease for one, an increased
understanding of sample sizes over time allows us to transition to using smaller samples
while still provide a similar confidence of results. This could suggest improved
understanding of sample size and adequate power in more recent years, allowing for
smaller samples to be used. Further, large surgical trials assessing general questions have
likely been undergone earlier in the years, and it would be unethical to reproduce these
trials as we have a strong understanding of the results. Accordingly, esoteric demands
and subdomains of these general matters are more likely the question at hand for the
studies conducted in more recent years which don’t affect the general population rather a
smaller, more niche subgroup which allows for a smaller sample size.

2.4.1 Limitations
Since we had to rely on the information provided in the ClinicalTrials.gov registry
for information on the studies, some information may have been incomplete, especially if
the trial registry authors failed to enter the correct information or did not update the
registry to reflect changing status over time. It was assumed that these registries were up
to date and accurate for analysis purposes, and the result of our study needs to be
interpreted in this light. Similarly, due to the volume of studies, it was not feasible to go
through all 13,761 and check publication status; therefore, we relied on the status posted
within the registries for this information as well. In this case “completion” does not
necessarily mean “published”, but rather that the studies ended normally, and participants
are no longer being examined or treated.

2.4.2 Conclusion
While registered surgical RCTs are increasing over the past 20 years, there
remains a substantial proportion that are unpublished. Implications and concerns for
research integrity are present,, but without further analysis on the unpublished work it is
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difficult to make further assumptions.17 Additionally, the staggering proportion of studies
within very high and high-income countries raises concern for the generalizability and
applicability of the evidence urging future research to resemble more balanced proportion
of study production and surgical type in relation to where the world’s population lies.
This is an issue to be addressed by policy makers, research funders, journals, and related
institutions to help increase the range in surgical research and enhancing proportional
capabilities for producing research.
After the totality of global surgical research has been characterized, it is necessary
to further explore the publication status of these studies, and information within these
publications. In Chapter 3, we will take a sample of the registered studies and search for
publications in order to identify the rate of publication. Additionally, we will compare
outcomes from the registries to the publication to analyze outcome distortion, spin, and
the overall integrity of the studies.
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Chapter 3

3

Categorizing and Describing Spin in Surgical Research
High quality research, including randomized controlled trials (RCTs), is necessary

to inform decisions about what works in clinical research.8 However, incentives to distort
research and spin the results into positive outcomes to produce results that seem more
interesting threatens the integrity and validity of research.15 We obtained a sample of
surgical RCTs registered in ClinicalTrials.gov between 1997 to 2017 in order to
characterize completion rate, publication rate, and frequency of positive results.
Additionally, this allowed us to quantify detectable distortion and spin in the presentation
of the published results in order to characterize the integrity of the evidence base and
identify opportunities for improvement.

3.1 Introduction
In a high stakes field such as surgery, research conducted and reported with
integrity and transparency is essential since evidence-based decisions require access to
complete and unbiased information. Randomized controlled trials (RCTs) are essential to
inform decisions about which surgical interventions work, and well-conducted RCTs are
generally considered the highest level of evidence. However, pressure to publish and
tendency to report more interesting results has led to a significant tendency to ‘spin’ the
results to increase likelihood of publication and to garner attention from readership and
the media. These pressures may incentivize subtle efforts or even outright blatant efforts
to manipulate results in order to display a positive, or statistically significant, outcome.15

Spin can be defined as the deceptive use of language to either mask unfavourable
results, place an emphasis on favourable results, or state misleading conclusions often
with causal language suggesting something that is not supported by the results.16
Similarly associated with misleading behaviours, outcome distortion refers to numerical
results or analyses where negative results are selectively reported or omitted, as well as
the replacement of non-significant outcomes with other significant ones such as in the
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case of a primary outcome demotion substituted with a significant one, or promoting
significant over non-significant results.17 The presence of either of these alterations
jeopardizes integrity at the individual trial level, and may bias the evidence base as a
whole, through overestimation of positive results and under-reporting of negative results.

The consequence of these manipulations includes post-hoc biases known as
publication bias and citation bias. Both biases measure the effect of falsely interpreting
and presenting the results in order to be perceived as more positive than they are (beyond
what is supported by the data).17 Publication bias occurs when positive studies are overrepresented in the published literature, and negative studies are more likely to be missing
(failure to publish at all, or longer time to publication), due to a variety of interdependent
forces that incentivize authors and journal editors to favour positive findings.18

Citation bias is the notion that positive studies are more likely to receive more
citations, thus making them more discoverable to the public.17 This can be analyzed
either through the number of citations received by a study or by the impact factor of the
journal of publication, as more credible journals tend to have a higher visibility. These
factors correspond to the number of citations a journal receives, which is quantified by
the Journal Impact Factor (JIF) using scientometrics to assess the visibility of a
journal. When visibility of positive results is heightened through greater propensity to be
accepted in a high-impact factor journal and greater propensity to be cited, this further
reinforces positive results to be overestimated in the literature.17

A main motivation for manipulation of the results is publication in a credible
journal. Publication is rewarding to researchers and their affiliated institution as it
demonstrates academic achievement, increases credibility, and in turn, leads to potential
increases in funding and future opportunities.13 To reduce publication bias and outcome
distortion, prospective registration of clinical trials has been proposed to ensure a priori
declaration of study details to improve accountability to maintain their intentions, or
transparently announce changes.10
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Registration for all clinical trials of drugs, biological products or medical devices
(excluding feasibility trials) has been made a legal requirement from September 27, 2007
and onwards to be eligible for publication in select high-impact journals according to the
Food and Drug Administration Amendments Act, and similar guidelines are followed by
other regulatory bodies.12 Even with this mandate, annual the rate of publication is
increasing at a rate of about 2-3% in the mid 1900s, and increasing to 8-9% rate
approaching 2012.14 The ratio of positive versus negative studies in the literature is also
growing rapidly.26 A 2017 study reported that the proportion of positive results in 19901991 was 70.2%, increasing to 85.9% in 2007.26 While positive findings provide vital
information, negative or null findings are equally important, and all results should be
published without bias preference toward positive or negative findings. Negative
implications of research integrity and concerns for validity are evident and must be
addressed.

Overreporting of positive results leads to biased estimates of the true effects of
interventions, since the best estimate of the ‘true’ effect requires all information to be
available from positive and negative studies so that a balanced estimate of net effect can
be provided. If positive results are preferentially cherry-picked and published, an
objective estimate of net effect is not possible. Biased estimates may be further reinforced
through meta-analyses that synthesize “all” discoverable studies, since negative studies
are less likely to be published, and if they are, they may be published after a longer time
delay than positive studies. Negative studies are equally necessary for researchers,
doctors, and policymakers to support objective evidence-based decision making.26

A number of efforts have been advocated to mitigate these biases, including
mandates for trial registration to ensure accountability, pre-registered reports to
incentivize publication of results without favouring positive over negative research
outcomes, and meta-research initiatives to detect biases in the reporting of research.17
Despite the increased attention to these risks to research integrity, greater efforts are
required to better characterize, quantify, and report the net impact of these biases. The
aim of this study is to identify and characterize overall bias including failure to publish,
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outcome distortion, and spin within a sample of surgical RCTs over the past two decades,
and to determine whether there were significant differences between studies with positive
versus negative conclusions.

3.2 Methodology
From the full cohort of surgical RCTs registered in ClinicalTrials.gov between
1997-2017 (n=13,761) previously described in Chapter 2 (refer to Chapter 2,
Methodology, Section 2.2.), we obtained a sample (n=5,094) and attempted to identify all
publications matching the registered studies in order to quantify publication rates, from
which we calculated failure to publish. Since it was not feasible to extract data from all
published studies, we used sampling techniques from this cohort of studies to identify a
representative subset of studies with matching publications to enable in-depth analysis of
extracted data to quantify selective outcome reporting and spin in the published studies.
Detailed methods are provided below.

3.2.1
Rate

Searching for Published Articles to Quantify Non-Publication
To inform the publication rate for the sample of studies (n=5,094), we first limited

the registered surgical RCTs to the set that had begun enrolment (n=4,652), and for these,
we searched for the corresponding published article(s) within the registered RCTs
recorded on ClinicalTrials.gov, as many investigators will list the relevant publications
there upon completion. However, since many investigators fail to list the publications
stemming from the registered research, it was also necessary to search the medical
literature more extensively. To match the studies that did not have their corresponding
publications included in the registry, we used a custom Python program (Appendix 5) to
find the best-matched articles on PubMed and PubMed Central based on the available
information provided in the registration on ClinicalTrials.gov. If the program was unable
to identify the publication(s), all relevant criteria from the registry (including NCT
identifier, official title, authors, other study identifier, intervention) were used to
manually search Medline and Google Search for any relevant articles. If publication(s)
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could not be found through using the custom Python program and a minimum of 5
minutes of manual searching had elapsed, it was deemed that the study was not published
at the time of searching. Matching the studies to their corresponding publications took
place between mid-November 2020 to the end of July 2021. Using the publications
identified, we first quantified the overall publication rate for the sample of registered
RCTs, and also used this to quantify failure to publish.

3.2.2 Sampling Methods to Identify a Subset of Published Studies for
In-Depth Review
Due to the large corpus and time constraints, a sample of studies was selected for
review. Within this sample, the identified published studies were further randomly
sampled for data extraction. However, to ensure that we had an even distribution of
studies from each year, we first performed an intentional selection with 10 studies
consisting of the 5 highest and 5 lowest enrollment sizes as reported by the research on
their registry. After the intentional selection was complete, the following rounds each
consisted of randomly selected studies proportional to the number of studies registered in
that year, using 2.75% of the registered studies per year each round. The samples were
randomly determined using Microsoft® Excel (v.16.51). This process was repeated until
data saturation was reached; that is, the point where no new information is obtained by
collecting further data as defined by no meaningful difference in the proportion of studies
with selective outcome reporting and spin after data for at least three successive samples
of studies had been extracted. To validate our claim of saturation and generalizability, we
also compared the baseline characteristics of the subset of studies with that of the original
large cohort of studies to check whether the distribution of types of surgical procedures
and distribution across human development indices (HDI) and geographic region was
similar.
After using sampling techniques to identify a representative subset of registered
studies with matching publications, we used the publications for in-depth data extraction
to quantify the incidence of outcome distortion and spin (defined below) for all the
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studies included in the subset, subdivided by studies with positive and negative results,
separately.

3.2.3 Data Extraction
Data extraction for characteristics available in the registry were described in
Chapter 2, Section 3.2, Methodology. In addition, for this chapter, we examined other
characteristics of the clinical trials, including enrollment size, outcomes, indicators to
inform spin, indicators to inform outcome distortion, and their impacts including number
of positive studies, citations, journal impact factors, and time to publication. See
Appendix 7 for the extraction guidelines for the categories and their definitions. Data
extraction occurred between January 2021 to July 2021.

3.2.3.1 Outcome Definitions – Publication Rate, Failure to Publish,
Outcome Distortion, Spin
Key outcomes of interest included proportion of registered studies that were
published, and of those, how many were positive, and turned positive due to outcome
distortion or spin. Statistical comparison of characteristics associated with positive
studies versus negative studies was planned in order to assess whether positive studies
were associated with outcome distortion, spin, and shorter time to publication.

Publication rate was defined as the total number of RCTs registered on
ClinicalTrials.gov between 1997-2017 with at least one identifiable publication, as of
July 2021. Failure to publish was defined as (1 – publication rate).

Outcome distortion was defined as the presence of one or more of the following
questionable reporting practices relating to outcomes when comparing the original study
registration versus the publication, in alignment with the definition previously provided
by Devries et al: 17 removal of non-statistically significant primary outcomes, addition of
statistically significant primary outcomes, changes in planned time frame for the primary
outcome, or omission of intended primary outcomes entirely. To measure distortion, we
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compared up to the first five primary outcomes reported in the RCT registration on
ClinicalTrials.gov (which we refer to as intended primary outcomes) to the outcomes
actually reported in their publication (which we refer to as reported primary outcomes).
Specifically, we recorded the direction (positive or negative), effect measure, and
significance of the results (using p-values, confidence intervals, or written suggestion if
other indicators were not identified). We also recorded whether the intended primary
outcomes were adequately defined and if the reported primary outcomes were clinically
relevant. Secondary outcomes were also obtained from the registry and the published
studies. However, detailed information on significance and effect measures were not
recorded for secondary outcomes, and due to time limitations, we focused only on
alterations of primary outcomes. Further details can be found in Appendix 6 and Table 4.
Spin is a “specific reporting strategy” involving result misrepresentation that can
“highlight that the experimental treatment is beneficial, despite a statistically
nonsignificant difference for the primary outcome, or to distract the reader from
statistically nonsignificant results”.15 In this study, we focused on spin in the conclusion,
where the overall interpretation and presentation of the outcomes was addressed. To
measure spin in the studies, quotes of the concluding statement from the abstract and the
discussion section were retrieved and categorized into positive or negative outcomes,
where a negative outcome suggests that there was no significant difference in the
interventions, and a positive outcome suggests that there was a difference. This allowed
us to determine whether the study results were turned positive if the primary outcomes
were actually non-significant. Along with this, levels of spin in the conclusion were
classified as low, medium, or high as per definitions from Boutron and colleague's
classifications and definitions of spin (Appendix 6).15 Refer to Table 4 below for details.
Table 4: Definitions for outcomes distortion and spin
Category
Outcome Distortion
Spin
Definition

The presence of questionable

Misrepresentation of results to

outcome reporting practices when

“highlight that the treatment is
beneficial despite a non-significant
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comparing the registration versus

difference for the primary outcome, or

the published study.

to distract the reader from statistically
non-significant results.”15

Examples include switching

Note that this differs from Outcome

primary outcome to achieve

Distortion since it is an assessment of

significance, or downplaying

the appropriateness of the authors’

preplanned primary outcomes

interpretation of the results as

when non-significant, or revising communicated in the published
the definition of the primary

conclusion.

outcome or its timepoint to
achieve significance.
What was

Changes in primary outcomes

Overall conclusions declared in the

compared

intended (from the RCT

published article versus the

registration) versus primary

underlying supporting evidence.

outcomes actually reported (from
RCT publication)

Details for

Primary outcomes intended and

Quotes from abstract conclusion or

what was

their significance, primary outcomes main manuscript conclusion, followed

extracted

reported and their significance, and by judgement of whether this was
information to determine whether

considered low, moderate, high spin

any of the following occurred:

or no spin at all according to Boutron

- a non-significant primary outcome definitions: 15
was demoted

No spin: “the conclusion is consistent

- a significant secondary or other

with the results and highlights adverse

outcome was promoted to primary

events”

-intended primary outcomes were

Low spin: “acknowledgment of the

entirely missing

statistically nonsignificant results for

- time frames for outcomes were

the primary outcome OR uncertainty

different from intended

and recommendations for further
trials”
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Moderate spin: “no acknowledgment
of the statistically nonsignificant
results for the primary outcome AND
uncertainty or recommendations for
further trials”
High spin: “no acknowledgement of
the statistically nonsignificant results
for the primary outcome AND no
uncertainty AND no
recommendations for further trials”
(Appendix 6).15

Where it was Results section

Abstract conclusion or main

found

manuscript conclusion

3.2.3.2 Definition for Impacts of Distortion: Positive Studies, Citations,
Journal Impact Factor, and Time to Publication
To further characterize measurable impacts of publication bias, outcome
distortion, and spin, we analyzed the proportion of positive studies, the number of
citations a study received, the journal impact factor, and time to publication.

A positive study was defined as one where the conclusion declared a significant
difference between interventions. A negative study was defined as one where the
conclusion did not declare a significant difference between interventions. We determined
whether a study concluded positive or negative results from the abstract conclusion where
the overall difference between interventions was reported. In the rare case that there was
no abstract, the discussion conclusion was used to classify the study as positive or
negative based on the description of the overall study results.
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The proportion of positive studies was calculated by taking the number of
positive studies and dividing it by the total number of published studies. The proportion
of studies that turned positive was calculated by taking the number of studies that
turned positive and dividing it by the denominator which is the number of all studies.
Studies could “turn positive” either through distortion of outcomes, or through spin in the
conclusion. As a sensitivity analysis, the proportion of positive studies that were
turned positive was also calculated by taking the number of studies that turned positive
as the numerator and dividing it by the number of positive studies, which we set as the
denominator.

The number of citations for each published study was retrieved from Google
Scholar. The journal impact factor was defined as that provided by Clarivate Journal
Citation Reports page according to the year of study publication.27 If the journal impact
factor could not be obtained, then it was defined as unknown. Additionally, since at the
time of data extraction, the journal impact factor for the year 2021 had not been released.
Therefore, for studies published in 2021, the 2020 JIF was assigned since there is limited
variability from year to year.

Time to publication was determined by taking the duration (in months) between
the date of study registration on ClinicalTrials.gov and the date of online publication. If
the full date was not available, the first day of the month was taken or the first day of the
year if the month of publication also was not found.

In the case that multiple publications resulted from a single trial registration, the
first publication was preferentially extracted for descriptive characteristics. However, all
relevant publications were examined for comparing between the outcomes declared in the
registration versus those actually published, and all relevant publications were explored
for the significance analysis. This was to ensure that longer time frames were considered
for outcome reporting bias purposes as authors often published multiple time frames prior
to their longest intended one.
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3.2.4 Statistical Analysis
Microsoft® Excel (v.16.51) was used for descriptive statistics. Statistical
inferences were calculated using RStudio (Version 1.2.5019).28 Chi-square test was
performed for categorical outcomes, while Welch’s two sample t-test was performed for
continuous data, where a two-sided p<0.05 was considered statistically significant.

An icon array was created on Infogram.com to show the proportion of studies that
progressed from registration to publication. The stages of this progression included all
surgical RCTs registered between 1997-2017, studies that began enrollment, and studies
that were published. Studies that were registered were analyzed from the sample of
studies that were evaluated to see if the published version could be found. Studies that
began enrollment were retrieved from ClinicalTrials.gov, and if their reported enrollment
size was larger than 0, it was assumed that enrollment had begun. We created a second
icon array to show the degree of outcome distortion and conclusion spin compared to the
intended outcome from the published studies. A study was considered to have turned
positive if the intended primary outcome was either negative, unknown or mixed based
on the primary outcomes intended from the registry, and the overall conclusion of the
study had reported a positive or a significant conclusion.

Regression analyses were performed using RStudio (v.1.2.5019) to explore the
change in positive studies over time.28 Logistic regressions were performed using a quasibinomial distribution with year as predictor variable for three categories including the
proportion of positive studies, the proportion of studies that turned positive, and the
proportion of positive studies that were turned positive. We also explored the proportion
of studies that were turned positive by using three different characteristics: studies turned
positive due to outcome distortion, due to spin, and overall.

3.3 Results
3.3.1 Included Studies & Publication Rate

38

In total, 13,761 registered studies were included in the original full database of
registered surgical RCTs. Baseline characteristics of these studies are summarized in
Chapter 2, Table 1. After 5 rounds of sampling from the original database of 13,761
registered RCTs, saturation was reached, and the resulting subset of 5,094 studies was
used for in-depth data extraction. Of the 5,094 registered studies subjected to medical
database searches in an attempt to match them to their published results, only 1,718 had
published results (Figure 1). This represents a publication rate of 33.7% (1,718/5,094),
and a failure to publish rate of 66.3%.

3.3.2

Study Characteristics

Figure 6: Flow chart of study process from screening to data extraction
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Characteristics of this sample of studies in which their publication was found
(n=1,718) are summarized in Table 5 and are comparable to baseline characteristics of
the original larger cohort of surgical RCTs described in Chapter 2, Table 1. Median
enrollment size was 92 (IQR: 51-186) and mean was 322 (range: 5-18,876). The majority
of trials were conducted in countries with a very high Human Development Index (HDI)
(78.6%) or high HDI (18%) and were largely conducted in Europe (50.2%) and the
Americas (27.7%). The four most common surgical categories included: Orthopedics
(20.5%), Cardiac, Vascular and Thoracic (14.4%), Gastroenterology (14.2%) and
Obstetrics and Gynecology (10.4%).

Since our sample consists only of studies that had been published, it is expected
that the status of these studies would be “Completed” on ClinicalTrials.gov. However,
only 82% were labelled as such, which indicates failure of some investigators to update
their ClinicalTrials.gov entries upon trial completion. Further, 15% of these studies were
labelled “Not Completed”, and 4% were labelled “Ongoing”. Additionally, we found that
14% of studies had inadequately defined primary outcome(s) in their trial registration,
which suggests lack of transparency with their intentions during registration of their
clinical trial.

3.3.3 Study Characteristics for Positive versus Negative Studies
Out of the 1,718 studies retrieved for data extraction, 1,058 (62%) were positive
studies and 660 (38%) were negative studies. The proportion of positive studies differed
significantly across surgical categories (p=0.018) with the highest being Orthopedic for
both positive (19.5%) and negative (22.1%) studies, and the lowest being Thyroid for
both positive (1.5%) and negative (0.5%) studies. Mean enrollment size was significantly
larger for negative studies (p=0.069).

The Western Pacific Region had the highest proportion of positive studies at 70%,
whereas the African Region had the lowest proportion at 40%. Statistical inferences were
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not made for geographic regions since many studies had multiple regions and it was
difficult to attach a region to a single study. The proportion of positive studies was
similar across HDI categories (p=0.62), and across completion status (“Completed”, “Not
Completed”, and “Ongoing”) (p=0.15).
Table 5: Characteristics of published studies
Characteristic
Data Extracted Sample (n=1,718)
Total

Positive

Negative

(n=1,718)

Studies

Studies

(n=1,058)

(n=660)

No. (%)

No. (%)

No. (%)

P-value

Location by Region
Americas

749 (27.7)

403 (26.6)

346 (29.1)

748

608

1,356 (50.2)

(49.4)

(51.1)

Western Pacific

341 (12.6)

202 (13.4)

139 (11.7)

Eastern Mediterranean

160 (5.9)

112 (7.4)

48 (4.0)

South-East Asia

67 (2.5)

36 (2.4)

31 (2.6)

Africa

30 (1.1)

12 (0.8)

18 (1.5)

1,346 (78.6)

797 (75.8)

549 (84.2)

311 (18.2)

224 (21.3)

87 (13.3)

Medium

40 (2.9)

27 (2.6)

13 (2.0)

Low

6 (0.4)

3 (0.3)

3 (0.5)

39 (2.3)

28 (2.7)

11 (1.7)

Orthopedic

352 (20.5)

206 (19.5)

146 (22.1)

Neurology

27 (1.6)

19 (1.8)

8 (1.2)

Europe

HDI1 Category
Very High
High

0.62

Surgical Category
Breast

0.018
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Transplant

70 (4.1)

42 (4.0)

28 (4.2)

178 (10.4)

114 (10.8)

64 (9.7)

Plastic

33 (1.9)

19 (1.8)

14 (2.1)

Urology

82 (4.8)

48 (4.5)

35 (5.3)

Pediatric

82 (4.8)

58 (5.8)

24 (3.6)

247 (14.4)

138 (13.0)

109 (16.5)

Otolaryngology

36 (2.1)

18 (1.7)

18 (2.7)

Thyroid

19 (1.1)

16 (1.5)

3 (0.5)

88 (5.1)

59 (5.6)

29 (4.4)

Surgery

103 (6.0)

69 (6.5)

34 (5.2)

Ophthalmic Surgery

67 (3.9)

38 (3.6)

29 (4.4)

244 (14.2)

163 (15.4)

81 (12.3)

51 (3.0)

23 (2.2)

27 (4.1)

865

538

1,403 (81.7)

(81.8)

(81.5)

250 (14.6)

160 (15.1)

90 (13.6)

65 (3.8)

33 (3.1)

32 (4.9)

91.5

86

101

(51.0-186)

(50-155)

(56-242)

321.6

235.8

459.8

(5-18,876)

(5-13,698)

(9-18,876)

Obstetrics and
Gynecology

Cardiac, Vascular and
Thoracic

Dental, Oral and
Maxillofacial
Colon and Rectal

Gastroenterology
General
Completion Status3

Completed
Not Completed
Ongoing
Enrollment Size, median
(IQR)
Enrollment Size, mean
(range)

1. HDI = Human Development Index
2. Not applicable

0.15

<0.0001
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3. Author reported from ClinicalTrials.gov registry

3.3.3.1 Outcome Distortion
Incidence of outcome distortion in studies was 81% overall and was not
significantly different for positive versus negative studies (82% vs 80%; p = 0.37).
Incidence for the either outcome distortion, inadequate defining of outcome, or clinically
irrelevant outcomes was 91% total, with no significant difference for positive versus
negative studies (92% vs 87%, p=0.12). Sub-categories of type of outcome distortion are
outlined in Table 6. Overall, 14% of studies inadequately defined their primary outcomes,
11% had non-clinically relevant primary outcomes, and 80% had a discrepancy between
outcomes intended and actually reported. In addition, 10% demoted a non-statistically
significant primary outcome to secondary outcome, 14% promoted a significant
secondary outcome to primary outcome status, 13% did not report the primary outcome at
all, and 11% reported their primary outcome with a revised time frame. In total, 14% of
studies “turned positive” due to switching the originally planned primary outcome to
another significant outcome.
The sub-categories of outcome distortion that were significantly higher for
positive versus negative studies included non-clinically relevant primary outcomes (12%
vs. 8%, p=0.017), a statistically significant outcome promoted to primary status (20% vs.
3%, p<0.00001), and “turned positive” due to switching the originally planned primary
outcome to another significant outcome (20% vs. 3%, p<0.00001).

3.3.3.2 Spin
Incidence of spin was 39% overall and was significantly greater for positive
versus negative studies (45% vs 30%, p <0.00001). ‘High spin’ was found in 7% of all
studies and was significantly greater for positive versus negative studies (12% vs 0%, p
<0.00001). ‘Medium spin’ was found in 11% of studies overall and was significantly
greater for positive versus negative studies (18% vs 0.2%, p <0.0001). Low spin was
found in 21% of studies and was significantly greater for negative studies versus positive
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studies (30% vs. 15%, p<0.00001). Similarly, no spin was also significantly greater for
negative studies (70% vs. 55%, p<0.00001). Results turned positive due to spin in the
conclusion or selective outcome reporting in the conclusion in 16% of studies and was
significantly greater for positive versus negative studies (27% vs 0%, p <0.00001).

3.3.3.3 Citation Bias & Journal Impact Factor
Mean number of citations did not differ significantly between positive and
negative studies (68 vs 81; p=0.26). Mean JIF was significantly lower for positive
compared with negative studies (p<0.0001). In addition, positive studies had significantly
more missing JIFs (p=0.0068). Positive studies also had shorter time to publication
compared to negative studies (53 vs 67 months; p<0.0001).
Table 6: Statistical comparison of positive versus negative studies
Characteristic
Total
Positive Studies Negative Studies
(n=1,718)

(n=1,058)

(n=660)

No. (%)

No. (%)

No. (%)

Inadequately defined primary 242 (14.1)

P-value

163 (15.4)

79 (12.0)

0.071

184 (10.7)

131 (12.4)

53 (8.0)

0.017

1,398 (81.4)

868 (82.0)

530 (80.3)

0.37

1,373 (79.9)

848 (80.5)

525 (79.5)

0.76

169 (9.8)

99 (9.4)

70 (10.6)

0.40

outcomes
Non-clinically relevant
primary outcomes (reported)

Outcome distortion (at least
1 incidence)
Discrepancy in outcomes
reported and outcome
intended (primary and
secondary)
Non-statistically
significant primary
outcome demoted
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Statistically significant
233 (13.6)

215 (20.3)

18 (2.7)

<0.00001

225 (13.1)

141 (13.3)

84 (12.7)

0.72

190 (11.1)

122 (11.5)

68 (10.3)

0.43

232 (13.5)

213 (20.1)

19 (2.9)

<0.00001

674 (39.2)

476 (45.0%)

198 (30.0%)

<0.00001

High Spin

124 (7.2)

124 (11.7)

0 (0)

<0.00001

Medium Spin

193 (11.2)

192 (18.2)

1 (0.2)

<0.00001

Low Spin

356 (20.7)

159 (15.0)

197 (29.9)

<0.00001

1,044 (60.8)

582 (55.0)

462 (70.0)

<0.00001

280 (16.3)

280 (26.5)

0 (0)

<0.00001

outcome promoted to
primary
Intended primary
outcome not reported at
all
Primary outcomes were
the same but with
different time frames
Study “turned positive”
due to primary outcomes
yielding statistically
significant results when
intended had either nonstatistically significant or
unknown

Spin (any)

No Spin
Results “turned positive” due
to spin in the conclusion or
selective outcome reporting
in the conclusion

Citation bias/Publication
bias
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Number of Citations,
median (IQR)
Number of Citations,
mean (range)
Journal Impact Factor,
median (IQR)

Journal Impact Factor,
mean (range)
Journal Impact Factor,
number not available
Time to Publication

16 (4-47.8)

(months), mean (range)

15 (5-49)

68.3 (0-

81.2

2413)

(0-3024)

3.4

3.7

(2.2-5.4)

(2.4-6.9)

7.9

6.4

10.2

(0.09-91.3)

(0.09-91.3)

(0.23-91.3)

237 (13.8)

159 (9.3)

78 (4.5)

50 (35-73)
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58

(33-65)

(40-86.3)

53.4

67.1

(1-224)

(8-226)

73.3 (0-3,024)
3.5
(2.3-6.0)

(months) median (IQR)
Time to Publication

16 (4-47)

58.7 (1-226)

0.26

<0.00001

0.0051

<0.001
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3.3.4 Regression Results
Table 7: Logistic regression results for proportion of positive studies, proportion of
studies turning positive out of all studies, and proportion of studies turning positive
out of the positive studies
Proportion

Type of

Coefficient

Distortion

Beta

Standard Error

p-value

Estimate
Positive Studies

NA1

0.040

0.0131

0.0066

0.0033

0.016

0.84

Due to Spin

-0.028

0.014

0.056

Overall

-0.0092

0.013

0.51

Positive studies that Due to

-0.021

0.020

0.30

Due to spin

-0.062

0.018

0.0028

Overall

-0.046

0.018

0.018

Studies that turned Due to
positive out of all

outcome

studies

distortion

turned positive out outcome
of positive studies distortion

1. Not applicable for the proportion of positive studies

After exploratory logistic regressions shown in Table 7, multiple trends and
relationships regarding positive outcomes and studies that have turned positive were
observed. Figure 7 shows the increasing proportion of positive studies published each
year (Table 4: β=0.040, SE=0.013, p=0.0066).
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Figure 7: Logistic regression of the proportion of positive studies from 1997 to 2017
(numerator is positive studies, denominator is all studies)
In contrast, Figure 8 indicates that the proportion of studies that turned positive
decreased over time (Outcome Reporting p=0.84, Spin p=0.056, Overall p=0.51), and
most of this decline could be explained by decreasing incidence of studies that turned
positive due to spin. However, none of these was significant.
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Figure 8: Logistic Regression of the proportion of studies that turned positive from
1997 to 2017 (numerator is studies that turned positive, denominator is all studies)

As a sensitivity analysis, we also explored the proportion of positive studies that
were turned positive, where the denominator is the number of positive studies (rather than
a denominator of all studies) (Figure 9), and found a significant decline in proportion of
positive studies that were turned positive over time (Table 7: spin: β=-0.062, SE=0.018,
p=0.0028, overall: β=-0.046, SE=0.018, p=0.018), with most of the decline related to
proportion turned positive due to spin.
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Figure 9: Logistic regression of the proportion of positive studies that turned
positive from 1997 to 2017 (numerator is studies that turned positive, denominator
is all positive studies)
Together, these regressions suggest that even though there is an increasing
proportion of positive studies over the years, the number of positive studies that were
turned positive due to detectable spin or outcome distortion is decreasing over time.

3.3.5 Icon Array Displaying Sample of Studies Selected to Search for
Publication, and Distortion for Published Studies
To summarize the key results of this study into one figure, an icon array was
created to visualize the progression of studies starting from the sample of registered
surgical RCTs searched for evidence of publication (n=5,094), followed by studies that
began enrollment, and studies that were published (Figure 10). Further, from the studies
that had been published, the proportion of intended outcomes were displayed followed by
the actual outcomes reported, according to whether they were positive or negative
studies, and finally, according to the proportion of studies with detectable spin.
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Out of the sample of registered studies, only 33.7% were published, which
translates to a failure to publish rate of 66.3%. Of the originally intended primary
outcomes, 36.2% were positive (622/1,718). However, when analyzing the reported
outcomes, there were many more positive studies (61.6%), including a large portion that
turned positive from either negative, unknown, or mixed results (25.4%). The studies that
turned positive had the most spin detected within their conclusions. In total, the
proportion of registered studies that were published without outcomes turning positive or
detectable spin was only 18% (918/5,094). If all aspects of outcome distortion were
considered, the proportion of studies without outcome distortion or spin would be less
than 18% (not calculated in this study, due to non-mutually exclusive definitions for
distortion and spin).
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Figure 10: Icon array displaying the proportion of registered studies that were
published, and of those, what proportion were positive studies, what proportion had
outcome distortion, what proportion turned positive and what proportion had spin
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3.4 Discussion
While the number of surgical RCTs registered on ClinicalTrials.gov has increased
from 31 to 1,619 per year over the past 2 decades, only 34% of registered studies with
patient enrollment made it to publication, which translates to a non-publication rate of
66%. Of the 34% of registered studies that do make it to publication, 81% showed
evidence of outcome distortion, and 39% showed evidence of spin in the conclusion
(distortion and spin are non-mutually exclusive categories). Altogether, this study
provides tangible evidence of the troubling state of the surgical evidence base, a
significant proportion is entirely missing or reported with significant bias in order to “try”
to achieve significant results through manipulation and questionable reporting research
and reporting practices.

This low publication rate of registered RCTs provides direct evidence of
publication bias in the field of surgery and is even worse than the publication rate of 4650% detected in previous studies from other fields in medicine.29, 30 This raises questions
of why more registered studies that are started are not making it to publication. Whether
non-publication is due to study attrition (including slow enrolment, investigator fatigue,
changes in research priority due to evolving evidence elsewhere), failure to achieve
results that fit with preferred conclusions (preferring to suppress negative or unexpected
results), or lack of sufficient resources for investigators to complete the study, analyze the
results, and follow through to successful publication (publication requires iterative
submission cycles and responses to peer reviewer feedback) remains unknown. Further
research is required to ascertain the “failure rate” at each stage of research, from
registration to publication, in order to better inform how to mitigate research attrition,
misrepresentation of results, and overall research waste.

3.4.1 Study Characteristics
While the number of registered studies increased over years, study enrollment size
decreased in more recent years. The median enrollment size (92 patients) was smaller
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than the mean (322 patients), suggesting that earlier years had a larger enrollment size.
Potential reasons for increased studies with smaller size include possibility that a number
of large studies of the most prevalent conditions have already been done in earlier years,
leading to increasingly esoteric demands for sub-questions and subspecialty conditions
affecting a smaller subgroup of individuals. Other explanations might include an
increased number of clinical investigators vying for research, preferring to conduct
research independently rather than collaboratively.
A wide range of surgical categories was found in our cohort of registered RCTs.
However, the Americas and Europe dominated most of the RCT registrations, and almost
97% were from high HDI or very high HDI settings, again raising questions about
applicability and generalizability to regions of the world where the majority of the
population lives and where most of the unmet burden of disease amenable to surgical
intervention exists.
The mismatch between the proportion of studies labelled as ‘completed’ on their
ClinicalTrials.gov registry entry from the published sample is a concerning indicator of
the reliability of the registries, given that published studies generally indicate ‘completed’
studies. Even though mandates have been put in place to require completed registries in
order to publish in certain journals, updating registries is also important so that clinicians
and the public can stay informed on changes and progress made in the trials and
researchers can avoid duplicating research unnecessarily.
This concern is also amplified by the finding that 14% of RCT registry entries had
inadequately defined primary outcomes, suggesting that the study registration is no
guarantee of the quality necessary to maintain integrity and transparency in the literature.
Lack of adequate definition of outcomes, and failure to keep the registries up to date,
represents significant threats to the ability for registries to contribute to their aspired
quality improvement without adequate auditing and oversight for accountability between
registered plan versus reported study. Without full transparency, there is a temptation to
manipulate the data and frame it into whatever is giving the best story. The nebulousness
of the data when it is prospectively explained in this format allows for flexible reporting
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that is technically still abiding by typical journal publication requirements yet produces
ambiguous or misleading results which are amplified across the literature and decisionmaking.

3.4.2 Comparison of Positive versus Negative Studies
Out of the 1,058 studies reported as positive, only 622 (58.8%) were originally
positive before questionable research and reporting practices were applied to achieve a
positive outcome. In particular, a large portion of these would have been negative if the
original primary outcomes declared on the ClinicalTrials.gov registry entry had been
maintained and reported as originally planned, and if significant outcomes had not been
promoted in place of non-significant outcomes. Furthermore, it is important to note that
just because a study was published with negative results, does not mean that it was free of
bias or spin. For example, a study with a high level of spin could be ultimately negative,
but the results have been spun to seem more positive than initially intended.

With respect to measurable impacts after publication, positive studies were
published more than one year earlier than negative studies (53 vs 61 months), again
providing explicit evidence of greater propensity to publish positive studies. Whether this
is due to investigators’ greater motivation to submit positive results, or editors' propensity
to prioritize publishing positive results, or both, remains uncertain. However, negative
studies were associated with a significantly higher journal impact factor, and nonsignificantly higher citation scores. Therefore, although there is some evidence that
positive studies are favoured post-publication, they may not be consistently advantaged in
all aspects of attention scores.

Public efforts have been made in an attempt to increase trial registration to
increase transparency in published research, and recent improvements have been
reported.10,12 However, researchers still seem to find non-significant results
unsatisfactory, overlooking the importance of their contribution to the evidence base. A
2011 survey of authors indicated common reasons why outcomes were not reported
included: failure to understanding why it is important to report negative results, fear of
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data construed as uninteresting, not enough events worth reporting, and constraints
imposed by the journal calling for brevity or more space.31 Moving forward, focusing on
supportive regulations and incentivized approaches to research that coincide with the
issues at hand is vital in increasing transparency and integrity surrounding research.

3.4.3 Icon Array: Publication bias, Distortion, and Spin
As clearly shown by the icon array, there is a significant attrition in research from
registration with original intentions, to eventual publication of results. Out of the sample
of registered studies, only 34% were published, and of these, 61.6% were positive.
However, only 36.2% of those reporting their originally intended primary outcome were
positive. A large portion were ‘turned positive’ due to outcome distortion (13.5%) or spin
(16.3%). In total, the proportion of registered studies that were published without
outcomes being “turned positive” or without detectable spin was only 18%, and this
represents a conservative estimate. If all aspects of outcome distortion were considered,
the proportion of studies without outcome distortion or spin would be even less.
The cumulative effect of publication bias, outcome distortion, and spin is clearly
shown by the over-representation of positive studies in the cohort of published studies.
The impact is also seen in the propensity for positive studies to have higher levels of spin
and distortion than negative studies. Furthermore, distortion and bias also exist in
negative studies, where efforts did not go as far to manipulate outcomes or change the
conclusion, though there was still some indication of attempts to mislead true results even
in a sizable portion of negative studies.

3.4.4 Trends over Time
The results from the regressions offer insights into trends changing over time with
respect to the proportion of positive results, and the proportion of results turning positive.
A significant relationship was observed for the proportion of positive results and time,
indicating significant increase in positivity over the years. In contrast, the trend was
opposite for the proportion of studies that turned positive over time and was significant
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for two exploratory analyses (studies that were turned positive due to spin, and studies
that were turned positive overall). This might indicate that although positive studies are
increasing over time, it may not be due to detectable distortion, insofar as distortion is
detectable using the definition included in our study. Since distortion is difficult to trace,
and since our definition of distortion does not claim to be a comprehensive definition, the
estimates may be subject to detection bias and our limited definition. In addition, it may
also indicate the improvement of clinical trial investigators in revising their stated
primary outcomes on their ClinicalTrials.gov entry over time. Since we used the most
recently declared primary outcome from the ClinicalTrials.gov RCT registrations, our
definition of outcome distortion likely represents a conservative estimate compared to if
we had disallowed investigators’ revisions to primary outcomes definitions on the
registry post-enrollment. Even so, concerns of publication bias and over-representation of
positive results continue and should be further explored.

3.4.5 Strengths
This study should be interpreted in light of its strengths and limitations. Notable
strengths include the large size of the cohort of RCTs examined, which is beyond the size
of analogous studies in other areas of medicine that have evaluated outcome distortion
and spin.15, 16, 17, 18, 30, 31, 32 In addition, this study captured information across two decades
in order to explore trends over time, which is beyond that attempted by most other
analogous studies of questionable research practices. In addition to assessing distortion
and spin, we also assessed evidence of the impacts of distortion and spin, including the
proportion of studies that were positive, and the characteristics of studies associated with
distortion, spin, and declaration of positive outcomes. We also conveyed the key
outcomes of our study in an icon array, which communicates the attrition from study
registration, through to enrolment, and publication, and further indicates the evidence of
outcome distortion and spin (and the impact on positivity) within the cohort of studies
that make it to publication. This innovative approach to data visualization will help to
convey the complex interlinked concepts of publication bias, outcome distortion, and
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spin, and may spur increased awareness of research waste and biased reporting on threats
to objective, fully informed evidence-based decision making.

3.4.6 Limitations
A number of limitations existed when extracting information for trials registered
in ClinicalTrials.gov. For example, we assumed that if enrollment size was above 0 in the
registry entry, the trial was considered to have begun enrolment. However, this may not
always have been the case, and it was beyond the scope of this study to determine the
accuracy of enrolment sizes reported within ClinicalTrials.gov. In regard to the sampling
strategy, it was designed to capture an evenly distributed sample of studies proportional
the number of studies registered in each year and was large enough to view saturation
with respect to proportion of studies with selective reporting or spin. This measure of
saturation was chosen since it was the primary objective of the study. As a result, no
efforts were made to ensure that this sample was proportional across other secondary or
tertiary objectives, thus potentially bringing some disproportion to other aspects of the
studies.
Similarly, when published studies were incomplete and unclear, a number of
simplifying assumptions had to be made for primary outcomes, secondary outcomes,
significance and direction of the conclusions. For example, when the primary outcome
was not explicitly stated in the published study, the first outcome listed in the publication
was taken as the primary outcome in order to compare reported versus pre-planned
primary outcomes. Since we examined primary outcomes that were intended, at times
they were not able to be fully classified as positive or negative since the originally
planned primary outcome from the registered entry was not at all reported in the
published study, requiring us to categorize the primary outcome positivity as “unknown”.
Without access to unpublished data, it was not possible to determine the significance of
these outcomes, and we assumed that they were “turned positive” if the reported outcome
was positive (i.e., the outcome was switched from a non-reported primary outcome to a
secondary positive outcome).
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A further limitation is that our definitions for outcome distortion and spin were
not mutually exclusive, and consequently, we could not report a composite estimate for
this cohort of studies. In addition, our definitions for distortion and spin were likely
conservative definitions and could be expanded in the future. Lastly, we also were
conservative in our estimates of primary outcome switching, as we relied on the most
recently reported primary outcomes reported in the RCT registry entry, rather than
checking to see whether these had been changed post-hoc, or post-enrollment, by the
investigators (as is allowable on ClinicalTrials.gov).

3.4.7 Conclusion
In conclusion, multiple approaches to manipulation of research in order to achieve
positive outcomes is in evidence in the surgical evidence base. Over 61% of published
studies were positive, many of which were “turned positive” through outcome distortion
and spin. Positive studies had higher levels of detectable distortion and spin and were
published faster than negative studies. This concern further escalates when considering
that less than 34% of research that was planned and started has been published. To
protect research integrity and reduce research waste, urgent action is required to ensure
that evidence is published with full transparency, and that questionable research and
reporting practices such as distortion and spin are thwarted.
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Chapter 4

4

Categorizing and Describing Spin in HDI Categories
Conducting research proportionally to where the world’s population resides is

essential to improve applicability of research. In previous chapters, we have shown that
most studies are conducted in countries with a very high and high Human Development
Index (HDI). In this chapter, we further explore whether distortion and spin in studies
conducted in very high and high HDI groups differed significantly from studies in
medium and low HDI groups.

4.1 Introduction
Burden of disease and gross domestic product per capita are highly associated.33
Multiple factors, such as vaccination access, quality healthcare, sanitation, nutrition, and
housing, contribute to population health, social progress, and economic productivity.34 As
a result of multiple interposing factors, low-middle income countries (LMIC) experience
a higher burden of disease compared to high-income countries (HIC). Access to safe,
affordable, and timely surgery is scarce in low- and middle-income settings.35
Additionally, lack of funding and resources reduces opportunities for LMIC to conduct
the surgical randomized clinical trials, needed to generate evidence to inform safety and
efficacy of interventions within context. Conducting high-quality research proportionally
to where the world’s population resides is an important consideration to improve
generalizability and applicability of research. The objective of this study was to compare
the characteristics (size, type of procedure, enrollment size) and extent of outcomes
reporting distortion and spin in surgical RCTs registered between 1997 to 2017 for HIC
versus LMIC settings.

4.2 Methodology
For this chapter, we used the same data set (n=1,718) as Chapter 3 (for full details
of the methodology for extracting the data, refer to Chapter 3, Methodology, Section 3.2)
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with the focus on comparing between HDI groups. Due to the small number of studies in
low- and middle-income countries, the four HDI categories (low, middle, high, and very
high) were simplified into two categories for our analysis: high income countries (HIC)
(consisting of very high and high HDIs) and low- and middle-income countries (LMIC)
(consisting of low and middle HDIs). Fifteen studies that did not provide information for
where the study was conducted were excluded from the HIC versus LMIC analysis.

4.2.1 Statistical Analysis
Microsoft® Excel (v.16.51) was used to calculate summary statistics. Statistical
inferences were calculated using RStudio (Version 1.2.5019).28 This included the chisquare test for categorical data, and two-sample t-tests for continuous data (or Welch’s
two sample t-test when inequal variances were present). A two-sided p-value < 0.05 was
considered significant.
Logistic regression models using a quasibinomial distribution were used to
explore change over time in the proportion of positive studies, and the proportion of
studies that turned positive over time, using similar methods as described in Chapter 3,
with the addition of grouping the data according to HDI groups. Regressions were
performed using RStudio (v.1.2.5019).28

4.3 Results
4.3.1 Included Studies
An outline of the search results leading to the 1,718 published studies included in
this analysis, as well as a flow chart of studies, is provided in the previous chapter (Figure
6, Chapter 3). Study characteristics for the sample included in the analysis (n=1,718), and
according to HIC and LMIC subgroup, are provided in Table 9.

4.3.2 Study Characteristics for High-Income Countries versus LowMiddle Income Countries
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Study characteristics were reported for the entire sample of studies (n=1,718) and
according to country income category: high-income countries (HIC) and low-middleincome countries (LMIC). Since not all studies were able to be categorized into a
country, there are 15 studies (0.87%) that were missing from the HIC and LMIC
characterization. Out of this total (n=1,703), 1,657 studies (97.3%) are from HICs, and 46
studies (2.7%) are from LMICs. Studies from LMICs took place in the geographical
regions of the Eastern Mediterranean (21.6%), South-East Asia (54.9%), and Africa
(23.5%); no LMIC studies from the Americas, Europe, or the Western Pacific. In
contrast, most studies from HICs were in the Americas (28.2%), Europe (51.1), and some
in the Western Pacific (12.9%).
Since our sample consists only of studies that had been published, it is expected
that the status of these studies would be “Completed” on ClinicalTrials.gov. However,
only 82% of registered studies from HICs and 91% of registered studies from LMICs
were labelled as such, which indicates failure of some investigators to update their
ClinicalTrials.gov registration upon trial completion. Completion status was similar
between HIC and LMIC (p=0.28). Surgical categories differed significantly between HIC
and LMIC (p=0.023). In HICs, the top 3 surgical categories were Orthopedic surgery
(20.5%), Cardiac, Vascular and Thoracic surgery (14.7%) and then Gastroenterological
surgery (13.9%), whereas in LMICs, the top 3 surgical categories were
Gastroenterological surgery (26.1%), Orthopedic surgery (15.2%) and Obstetrics and
Gynecological surgery (13.0%). On the other hand, in HICs, the bottom surgical
categories were Breast (2.2%), Ophthalmic (2.2%) with several tied at 4.4%. In LMIC,
there were no studies that examined Transplant surgeries, Plastic surgeries, Colon and
Rectal surgeries, or Thyroid Surgeries.
The median enrollment sizes were comparable between HIC and LMIC (92 vs.
88), with a greater mean enrollment size in HIC, though not significantly different (327
vs. 205, p=0.058).
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Table 8: Characteristics of Published Studies
Data Extracted Sample (n=1,718)

Characteristic

Total
(n=1718)

Country where study took
place
HIC1

LMIC2

(n=1,657)

(n=46)

No. (%)

No. (%)

No. (%)

749 (27.7)

749 (28.2)

0 (0.0)

1,356 (50.2)

1356 (51.1)

0 (0.0)

Western Pacific

341 (12.6)

341 (12.9)

0 (0.0)

Eastern Mediterranean

160 (5.9)

149 (5.6)

11 (21.6)

South-East Asia

67 (2.5)

39 (1.5)

28 (54.9)

Africa

30 (1.1)

18 (0.7)

12 (23.5)

39 (2.3)

38 (2.3)

1 (2.2)

Orthopedic

352 (20.5)

340 (20.5)

7 (15.2)

Neurology

27 (1.6)

25 (1.5)

2 (4.4)

Transplant

70 (4.1)

69 (4.2)

0 (0.0)

178 (10.4)

171 (10.3)

6 (13.0)

Plastic

33 (1.9)

32 (1.9)

0 (0.0)

Urology

82 (4.8)

80 (4.8)

2 (4.4)

Pediatric

82 (4.8)

80 (4.8)

2 (4.4)

247 (14.4)

244 (14.7)

3 (6.5)

Otolaryngology

36 (2.1)

32 (1.9)

4 (8.7)

Thyroid

19 (1.1)

19 (1.2)

0 (0.0)

P-value

Location by Region
Americas
Europe

Surgical Category
Breast

Obstetrics and
Gynecology

Cardiac, Vascular and
Thoracic

0.023
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Dental, Oral and
Maxillofacial

88 (5.1)

83 (5.0)

4 (8.7)

Colon and Rectal Surgery

103 (6.0)

103 (6.2)

0 (0.0)

Ophthalmic Surgery

67 (3.9)

64 (3.9)

1 (2.2)

244 (14.2)

230 (13.9)

12 (26.1)

51 (3.0)

47 (3.8)

2 (4.4)

1,403 (81.7)

1350 (81.0)

41 (89.0)

250 (14.6)

242 (15.0)

5 (11.0)

65 (3.8)

65 (4.0)

0 (0.0)

91.5

92

87.5

(51.0-186)

(51-190)

(51.0-150)

321.6

327.0

204.6

(5-18,876)

(5-18,876)

(30-1,970)

Gastroenterology
General

Completion Status3
Completed
Not Completed
Ongoing

Enrollment Size, median
(IQR)
Enrollment Size, mean
(range)
1.

HIC = High-Income Country

2.

LMIC=Low/Middle-Income Country

0.28

0.058

3. Author reported from ClinicalTrials.gov registry

4.3.2.1 Outcome Distortion & Spin
Incidence of outcome distortion was 81% overall, and significant difference was
not found for HIC versus LMIC studies (82% vs 74%; p=0.18). Sub-categories of type of
outcome reporting distortion are outlined in Table 10. None of the sub-categories of
outcome reporting distortion were significantly different between HIC and LMIC studies.
Incidence of spin was 39% overall and did not differ significantly for HIC versus LMIC
studies (39% vs 37%, p=0.75) for any sub-category.
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4.3.2.2 Citation Bias & Journal Impact Factor
The proportion of positive studies did not differ significantly between HIC and
LMIC studies (61.6% vs. 65.2%, p=0.62). Mean number of citations was significantly
greater for HIC versus LMIC studies (75.4 vs. 14.7, p<0.00001). While mean JIF did not
differ significantly between groups (8.9 vs. 5.2, p=0.24), there was significantly greater
number of JIFs missing for LMIC studies (13.3% vs. 28.3%, p=0.0035). Mean time to
publication did not differ significantly between groups (58.9 vs. 58.8 months, p=0.98).

Table 9: Statistical Comparison of High-Income Countries versus Low-Middle
Income Countries
Characteristic

Inadequately defined primary
outcomes
Non-clinically relevant
primary outcomes (reported)

Outcome distortion (at least 1
incidence)

HIC1

LMIC2

(n=1,657)

(n=46)

No. (%)

No. (%)

P-value

237 (14.3)

4 (8.7)

0.543

175 (10.6)

6 (13.0)

0.80

1,353(81.7)

34(73.9)

0.18

1,329 (80.2)

34 (73.9)

0.16

164 (9.9)

4 (8.7)

0.79

Discrepancy in outcomes
reported and outcome
intended (primary and
secondary)
Non-statistically
significant primary
outcome demoted
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Statistically significant
225 (13.6)

6 (13.0)

0.92

215 (13.0)

6 (13.0)

0.99

185 (11.2)

5 (10.9)

0.95

225 (13.6)

5 (10.9)

0.26

651 (39.3%)

17 (37.0%)

0.75

High Spin

121 (7.0)

2 (4.0)

0.45

Medium Spin

186 (11.0)

6 (13.0)

0.71

Low Spin

343 (21.0)

9 (20.0)

0.85

1,006 (61.0)

29 (63.0)

0.75

271 (16.0)

7 (15.0)

0.84

1,021 (61.6)

30 (65.2)

0.62

outcome promoted to
primary
Intended primary outcome
not reported at all
Primary outcomes were the
same but with different
time frames
Study “turned positive”
due to primary outcomes
yielding statistically
significant results when
intended had either nonstatistically significant or
unknown

Spin (any)

No Spin
Results “turned positive” due
to spin in the conclusion or
selective outcome reporting in
the conclusion

Citation bias/Publication bias
Number of Positive Studies
Published
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Number of Citations,

16 (5.0-50.0)

median (IQR)
Number of Citations, mean
(range)
Journal Impact Factor,
median (IQR)
Journal Impact Factor,
mean (range)

75.4 (0-3,024)

14.7 (0-188)

3.5 (2.3-6.1)

2.2 (1.5-4.4)

(months) median (IQR)
Time to Publication
(months), mean (range)

79.3)

220 (13.3)

number not available

50 (35.0-73.0)

<0.00001

5.2 (0.09-

8.9 (0.17-91.2)

Journal Impact Factor,

Time to Publication

3.5 (0.3-14.0)

13 (28.3)

0.24

0.0035

48.5 (36.070.5)
58.8 (13-

58.92 (1-226)

168)

0.98

1. HIC = High-Income Country
2. LMIC=Low/Middle-Income Country

4.3.3 Publication Rate
Table 10: Number of registered studies that made it to publication
No Country
Sample

HIC1

LMIC2

Data

(n=5,094)

(n=4,432)

(n=90)

(n=572)

No. (%)

No. (%)

No. (%)

No. (%)

89 (98.9)

479 (83.7)

Stage of study

Began Enrollment3

4,652 (91.3)

4,084 (92.1)

Published

1,718 (33.7)

1,657 (37.4) 46 (51.1)

15 (2.6)

1. HIC = High-Income Country
2. LMIC=Low/Middle-Income Country
3. Had an enrollment size larger than zero in its Clinical Trials.gov registry
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An icon array was used to visualize the progression of studies from registration to
publication, and to display the differences between HIC and LMIC in this progression
(Figure 11). Out of the sample of 5,094 registered surgical RCTs, 4,652 (91.3%) of them
began enrollment, and 1,718 (33.7%) were published. LMICs had the largest portion of
studies making it to publication achieving a publication rate of 51.1% (46/90), and HICs
had a publication rate of 37.4% (1,657/1,718). Studies with no country data provided had
the smallest publication rate of 2.6% (15/572).

Figure 11: Studies analyzed from registration to publication separated into HIC and
LMIC
Note: Studies without country data (n=572) were excluded from this figure, and thus
there are 4,522 studies included for this analysis.
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4.3.4 Production of Studies for HIC and LMIC

Figure 12: Stacked bar graph of number and proportion of HDI categories from
1997 to 2017
HICs had the greatest number of studies, with a growing trend across the years.
LMICs experienced some growth over time, but still represent a minor proportion of
studies (Figure 12). The proportion of studies from LMICs has not shown consistent
growth. Registered surgical RCTs from LMICs did not appear in the ClinicalTrials.gov
until 2005 and are absent in 2012.
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4.3.5 Regression Results
Table 11: Logistic regression results for proportion of positive studies, proportion of
studies turning positive out of all studies, and proportion of studies turning positive
out of the positive studies subgrouped into high and low-middle income countries
Proportion

Type of

Subgroup

Distortion

Coefficient
Beta Estimate

Standard

p-value

Error
Positive Studies

NA

HIC

0.040

0.013

0.0064

0.028

0.11

0.81

0.0041

0.016

0.80

LMIC

-0.038

0.16

0.82

HIC

-0.027

0.013

0.053

LMIC

-0.023

0.16

0.89

HIC

-0.0075

0.013

0.59

LMIC

-0.075

0.16

0.66

Positive studies that Due to outcome HIC

-0.020

0.020

0.32

turned positive out of distortion

LMIC

-0.10

0.19

0.60

HIC

-0.062

0.018

0.0028

LMIC

-0.10

0.19

0.62

HIC

-0.044

0.018

0.023

LMIC

-0.16

0.21

0.46

LMIC

Studies that turned

Due to outcome HIC

positive out of all

distortion

studies
Due to spin

Overall

positive studies

Due to spin

Overall

1. Not applicable for the proportion of positive studies
Logistic regression was attempted for the proportion of positive studies, the
proportion of studies turning positive, and the proportion of positive studies turned
positive grouped by HIC and LMIC. We qualitatively observed increasing trends in both
HIC and LMIC for the proportion of positive studies produced each year seen (Figure
13), and this increase was significant only for HIC (Table 12: β=0.040, SE=0.013,
p=0.0064).
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Figure 13: Logistic regressions of the proportion of positive studies from 1997 to
2017 for HIC and LMIC (numerator is positive studies, denominator is all studies)

Figure 14 displays the proportion of studies that turned positive where we
observed a greater slope of decreasing proportion over the years for LMIC (Outcome
distortion p=0.82, Spin p=0.89, Overall p=0.66) than for HIC (Outcome distortion
p=0.80, Spin p=0.053, Overall p=0.59); however, significance was not found.
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Figure 14: Logistic regressions of the proportion of studies that turned positive from
1997 to 2017 for HIC and LMIC (numerator is studies that turned positive,
denominator is all studies)
As a sensitivity analysis, we also explored the proportion of positive studies that
were turned positive, where the denominator is the number of positive studies (rather than
a denominator of all studies) (Figure 15), and found a significant decline in proportion of
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positive studies that were turned positive over time for HIC (Table 12 HIC for Spin β=0.062, SE=0.010, p=0.0028 HIC overall β=-0.044, SE=0.018, p=0.023), with most of the
decline related to proportion turned positive due to spin. Regressions for LMICs were
underpowered due to few studies.

Figure 15: Logistic regressions of the proportion of positive studies that turned
positive from 1997 to 2017 for HIC and LMIC (numerator is studies that turned
positive, denominator is all positive studies)
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Overall, these regressions suggest that there is an increasing proportion of studies turning
positive over the years; however, the number of studies that were turned positive is
decreasing over time and is mainly attributable to decreases due to spin.

4.4 Discussion
4.4.1

Characteristics Compared to the World Population
Out of the cohort of studies included in our analysis of ClinicalTrials.gov between

1997-2017, an overwhelming proportion are from HIC (97.3%), which is not
representative of the world’s population distribution. 25 Only 2.7% of surgical RCTs were
from LMICs, where 42.7% of the world’s population resides (Table 13).

HICs show large and consistent growth in surgical RCT registrations over the
years. In contrast, LMIC studies appear first in 2005, and show sporadic growth without
stabilization in the upward trend. As a result, issues of generalizability to the world’s
population are seen and access and ability to conduct surgical research needs to be
improved in the LMIC.

Table 12: Comparison of geographical location of studies compared to the world
population. All values are displayed as percentages form the column total.
World Population 202125

Surgical Studies
Total

HIC (97.3) LMIC (2.7)

Total

HIC (57.3) LMIC (42.7)

Americas

27.7

28.2

0

13.2

21.8

1.6

Europe

50.2

51.1

0

12.1

20.6

0.6

Western Pacific 12.6

12.9

0

25.0

40.6

4.0

Eastern

5.9

5.6

21.6

9.3

6.4

13.2

South-East Asia 2.5

1.5

54.9

25.8

8.2

49.4

Africa

0.7

23.5

14.7

2.5

31.2

Mediterranean

1.1
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Most studies were from Europe (50.2%), Americas (27.7%), and Western Pacific
(12.6%). In contrast, the world population has a much different order, where South-East
Asia has the largest population (25.8%), followed by Western Pacific (25.0%). Thus,
there is a large discrepancy between the proportion of RCTs performed geographically
and the proportion of where the world’s population lives which raises issues of research
equity and generalizability.

4.4.2 Volume of Research & Growth over Time
Due to the costs, elaborate infrastructure, and education required for surgical
procedures, access to surgery remains challenging for LMICs.36 Therefore, it seems
plausible that there are less surgeries occurring in LMIC, and fewer opportunities for
surgical research. However, access to surgery is an essential component of universal
healthcare and has been shown to be cost-effective for several life- and limb-saving
procedures. Despite the known resource barriers and scarce access to surgical care, it is
disappointing that only 2.7% of surgical studies have come from these areas, while 42.7%
of the world’s population lives in LMIC.36 Together this highlights the need for improved
resource distribution in these regions.

HICs show large and consistent growth in surgical RCT registrations over the
years. In contrast, LMIC studies appear first in 2005, and show sporadic growth without
stabilization in the upward trend. As a result, issues of generalizability to the world’s
population are seen as well as access and ability to conduct surgical research needs to be
improved in the LMIC.

4.4.3 Characteristics Relating to Areas of Distortion
Categories of distortion were similar between HIC and LMIC. The number of
positive studies and time to publication was similar between the groups. A standout
difference was the greater number of citations for studies from HICs compared with
LMICS. Cases for journal impact factor not found was higher for LMIC. When a JIF is
not available it can suggest that the journal is not credible or does not meet criteria for
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listing in the Clarivate JIF resource, thus potentially overestimating the JIF that was
calculated for the LMIC and resulting in the true median and mean JIF to be even
lower.36

4.4.4 Publication Bias within HIC vs. LMIC Studies
While many registered studies were started, just 33.7% made it to publication,
which is direct evidence of publication bias. In our analysis, HICs had a higher nonpublication rate than LMICs, also raising questions why HICs, with their greater access
to resources and research, are less likely to publish than LMICs where resources and
research are scarcer.

4.4.5 Regression Results
Regression analyses show that there is an increasing proportion of positive studies
over time, qualitatively observed for both HIC and LMIC. The lack of power jeopardizes
conclusions about difference in trends between groups over time. The higher proportion
of positive results each year raises questions as to why more negative studies are not
being published and is likely evidence of publication bias. The fact that the majority of
studies are positive is suspect, given that the median size of the studies was low, and
hence unlikely to be sufficiently powered to show positive effects most of the time. On
the other hand, some might suggest that increasing proportions of positive conclusions
also raises questions about whether more studies are positive due to more studies being
conducted unnecessarily in the face of higher known a priori likelihood of success.
However, this raises questions about whether an increasing number of studies are done
where there is no longer equipoise, but rather the answer is already “known”, or a
foregone conclusion. If this is the case, this would suggest possible research waste due to
unnecessarily repeated studies for answers that were already known. Further research on
the adequacy of study power and the presence of prior probability of this cohort of
studies would be required to determine whether the increasing positivity in clinical trials
is mostly due to spin, or whether there is also a propensity toward unethical or
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unnecessary repeating studies with higher probability of success than equipoise would
afford.

4.4.6 Limitations
This research should be interpreted in light of its limitations. Since country where
the study has taken place was challenging to identify when not clearly listed in
ClinicalTrials.gov, there may have been some misclassification of studies, though the risk
is likely low since only 15 (0.87%) entries could not be categorized by country.
Another limitation includes the small number of studies in the LMIC category,
resulting in underpowered analyses for subgroup comparisons of outcome distortion and
spin. In particular, the logistic regressions may be unreliable due to the small number of
studies from LMICs, with large dispersion.
In addition, the sample of studies included in this analysis was derived from
registered RCTs with an identifiable and retrievable publication. Since publications from
LMICs may be differentially identifiable and retrievable compared to HICs, this may
have introduced bias in our dataset. Lastly, to account for studies that began enrollment,
we made an assumption that studies with an enrollment size of larger than 0 the
ClinicalTrials.gov registry indicated that the study had started, and some studies may
have been missed due to failure of investigators to update their RCT registry page with
enrolment numbers. However, this would be a concern only to the extent that registered
trials without updates are systematically different than registered trials without updates
on enrolment in the ClinicalTrials.gov database.

4.4.7 Conclusion
While the volume of surgical RCTs is increasing, more than 96.4% are conducted
in HIC, where less than 57.3% of the world’s population lives. Fewer than 2.7% of
studies are conducted in LMICs, where the greater global burden of disease amenable to
surgical care exists. This incongruity raises concerns about research equity, applicability,
and generalizability. Our analysis did not provide evidence of differential risk of outcome
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distortion and spin between HIC and LMICs. Nevertheless, HIC studies receive a greater
number of citations, which correlates to greater opportunity for visibility and future
funding, which may generate a self-fulfilling prophecy of continued incongruous research
power in HIC settings. This research inequity should be addressed in future studies by
journal editors, funders, policy makers, and research institutions in order to bridge the
gap in LMIC surgical research.
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Chapter 5

5

Integrated Discussion and General Conclusions

5.1 Overview
This research describes the characteristics of the current state of surgical research
and identifies areas of distortion regarding research reporting. Randomized controlled
trials (RCTs) registered on ClinicalTrials.gov from 1997 to 2017 involving patients
undergoing a randomized allocation for a surgical intervention were extracted and
analyzed to compare general characteristics, and relationships relating to distortion of
results. These studies were further explored to focus on three overall objectives:

1. To describe the global body of surgical research for RCTs and identify
disproportionate representation of specific characteristics including country
and income-level where the study took place, surgical category, and
completion status.

2. To determine the common areas of distortion in the surgical evidence base
and quantify the overall level of distortion including failure to publish, spin
and distortion of outcomes.

3. To identify and quantify the areas of distortion in the surgical evidence
base and determine whether areas of distortion in the surgical evidence base is
correlated to income-level of the country where the studies took place as we
compared characteristics between high-income countries (HIC) and lowmiddle income countries (LMIC).

5.2 Integrated Discussion of Results
The function of evidence-based research serves to provide the highest quality of
research for further implementation in healthcare and decisionmaking.8 Thus, it is
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necessary to ensure research is being produced with high integrity, that proportionally
represents the world’s population. Chapters 2 focuses on describing characteristics of the
global surgical research pool to evaluate shortcomings in the global representation.
Chapters 3 and 4 take a sample of the studies and explore the levels of failure to publish,
as well as distortion and spin within the studies and comparisons of certain characteristics
including differences between positive and negative studies, and differences between
high-income and low-middle income countries respectively.
Chapter 2 showed an overall increase in the number of studies registered on
ClinicalTrials.gov each year, creating a relatively large volume of surgical RCTs.
However, a large portion of these studies remain unpublished, with this portion
decreasing as the years progress. According to author-identified completion on the
registry, only 57% of the overall studies reached completion with 84% completed in 1997
and 39% completed in 2017. Also decreasing throughout the timespan was enrollment
sizes of studies, with a larger decrease in the completed studies. Additionally, a
significant portion (76.8%) of studies have been conducted in very-high income
countries, while only 19.9% of the world resides in these regions.
In Chapter 3, we aimed to conduct a more specific analysis of characteristics
across studies and dive deeper into the studies to identify areas of spin or distortion. To
do this, we obtained a sample of registries and searched them for the published studies.
From the sample of 5,094, only 1,718 were published (34%). From this published sample,
62% declared a significant conclusion (1,058/1,718) of which 41% was not intended to
be positive based on the registry, rather turned positive due to either spin or outcome
distortion. Overall, the trend for reporting positive studies is significantly increasing over
the years. However, the trend for studies that turned positive (out of the positive studies)
is significantly decreasing over the years for turning positive due to spin and overall.
Finally, positive studies are on average published in journals with lower impact factors
compared to studies with negative conclusions (6.4 vs. 10.2, p<0.00001), while their
medians are relatively similar (3.4 vs. 3.7), and there is no significant difference for
number of citations between the groups (p=0.26). Positive studies are seen to have a
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faster time to publication for mean (53.4 vs. 67.1 months, p<0.001) and median (46 vs.
58 months) and have more studies with unavailable journal impact factors (9.3 vs. 4.5,
p=0.0051).
With a large proportion of studies produced in HIC, in Chapter 4 we aimed to see
if income level of a country is related to differences in study characteristics and levels of
spin and distortion. As seen in Chapter 3, a small proportion of studies made it to
publication (34%). When comparing this between the income-levels, both groups had
similar proportions that began enrollment (HIC: 92.1% vs. LMIC: 98.9%), while LMIC
had a larger proportion that made it to publication (51%, 46/90) when compared to HIC
where only 37% (1,657/4,432) made it to publication. This suggests that HIC have a
greater failure to publish rate. There were no significant differences of spin or distortion
between HIC and LMIC studies; however, HIC showed a significantly increasing trend of
positive study production over the years (p=0.0064), while also showing a significantly
decreasing trend of positive studies that turned positive over the years for turning positive
due to spin (p=0.0028) and overall (p=0.023). While LMIC followed similar trends, none
of them was significant. Finally, there were no significant differences between number of
positive studies (HIC: 61.6 vs. LMIC: 65.2), journal impact factors (mean: 8.9 vs. 5.2
p=0.24, median: 3.5 vs. 2.2), or time to publication (mean: 58.9 vs. 58.8 months p=0.98,
median: 50 vs. 48.5 months), between the groups. Significant differences were seen for
the average number of citations larger in HIC (75.4 vs. 14.7, p<0.00001) with higher
medians as well (16 vs. 3.5), and for journal impact factor not available, higher in LMIC
(13.3% vs. 28.3%, p=0.0035).

5.3 General Conclusions
When conducting research, taking measures to achieve the highest quality of
research is a necessary precaution in producing evidence-based research. Utilizing RCTs
in order to achieve a higher level of research is exemplary; however, the quality needs to
be integrated with a high level of integrity and careful attention when reporting the
outcomes.17
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Although positives are seen for the large volume of registered trials, concerns for
publication bias and research integrity are raised as a result of significant unpublished
work, and for the large proportion of increasing positive studies. Continued analysis of
the unpublished work is necessary to make further conclusions.

Trial registration is intended to maintain transparency when reporting results, in
order to reduce potential distortion that favour positive overall conclusions.17 A relatively
large portion of primary outcomes are inadequately reported, and lack of updates on the
registry for the completion status suggests that the registries are not being adequately
updated and carried through. High proportions of studies turned positive suggests that
registry authors aren’t being held accountable to their intended outcomes, and thus
threatening the validity of the study. Although trends of decreasing studies turned
positive is seen, further work for policy makers and those conducting research needs to
be implemented to reduce this impact even further.

5.4 Future Directions
A large area of concern identified within this research was the large volume of
unpublished work concerning registries that did not make it to publication. Future
research should involve the exploration of these unpublished trials to explore how far
they got and why publication has not occurred yet. This further investigation could
uncover additional information into publication bias within this field and provide insights
into why positive studies get published in a shorter time span, and why many of them are
published in unknown journals. Reintroducing the unpublished studies could additionally
strengthen the research base and aid in the evidence base practices for surgical research.
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Appendices
Appendix 1: Search terms put into the ClinicalTrials.gov expert search

( randomised OR RCT OR randomly OR AREA[TitleSearch] randomized OR
AREA[DesignAllocation] randomized ) AND ( AREA[InterventionSearch] ( surgery
OR transplant OR pancreatectomy OR pancreatoduodenectomy OR duodenectomy OR
splenectomy OR nephrectomy OR lumpectomy OR mastectomy OR gastrectomy OR
colectomy OR cholecystectomy OR appendectomy OR esophagectomy OR caesarean
OR c-section OR hysterectomy OR oophorectomy OR thoracotomy OR arthroplasty
OR “hip replacement” OR “knee replacement” OR prostatectomy OR rectopexy OR
dissection OR bypass OR operative OR operatively OR laparotomy OR neurosurgery
OR resection OR removal OR hepatectomy OR metastasectomy OR craniotomy OR
“valve replacement” ) OR AREA[TitleSearch] ( surgery OR transplant OR
pancreatectomy OR pancreatoduodenectomy OR duodenectomy OR splenectomy OR
nephrectomy OR lumpectomy OR mastectomy OR gastrectomy OR colectomy OR
cholecystectomy OR appendectomy OR esophagectomy OR caesarean OR c-section
OR hysterectomy OR oophorectomy OR thoracotomy OR arthroplasty OR “hip
replacement” OR “knee replacement” OR prostatectomy OR rectopexy OR dissection
OR bypass OR operative OR operatively OR laparotomy OR neurosurgery OR
resection OR removal OR hepatectomy OR metastasectomy OR craniotomy OR “valve
replacement” ) OR AREA[BriefSummary] ( surgery OR transplant OR pancreatectomy
OR pancreatoduodenectomy OR duodenectomy OR splenectomy OR nephrectomy OR
lumpectomy OR mastectomy OR gastrectomy OR colectomy OR cholecystectomy OR
appendectomy OR esophagectomy OR caesarean OR c-section OR hysterectomy OR
oophorectomy OR thoracotomy OR arthroplasty OR “hip replacement” OR “knee
replacement” OR prostatectomy OR rectopexy OR dissection OR bypass OR operative
OR operatively OR laparotomy OR neurosurgery OR resection OR removal OR
hepatectomy OR metastasectomy OR craniotomy OR “valve replacement” ) ) AND
AREA[StudyType] EXPAND[Term] COVER[FullMatch] "Interventional" AND
AREA[StartDate] EXPAND[Term] RANGE[01/01/1997, 12/31/2017]

87

Appendix 2: Results of search terms separated by year
Timeframe

Results

Timeframe

Results

01/01/1997 to 12/31/2017

24,740

01/01/2007 to 12/31/2007

1,027

01/01/1997 to 12/31/1997

62

01/01/2008 to 12/31/2008

1,338

01/01/1998 to 12/31/1998

104

01/01/2009 to 12/31/2009

1,390

01/01/1999 to 12/31/1999

125

01/01/2010 to 12/31/2010

1,542

01/01/2000 to 12/31/2000

163

01/01/2011 to 12/31/2011

1,706

01/01/2001 to 12/31/2001

227

01/01/2012 to 12/31/2012

1,751

01/01/2002 to 12/31/2002

298

01/01/2013 to 12/31/2013

2,035

01/01/2003 to 12/31/2003

373

01/01/2014 to 12/31/2014

2,238

01/01/2004 to 12/31/2004

569

01/01/2015 to 12/31/2015

2,573

01/01/2005 to 12/31/2005

722

01/01/2016 to 12/31/2016

2,755

01/01/2006 to 12/31/2006

861

01/01/2017 to 12/31/2017

2,881

Appendix 3: List of all countries represented along with their frequency, HDI value,
HDI category and region according to the World Health Organization (WHO)
HDI Value HDI
Country Name1

(UN) 2

Frequency

Argentina

72

Armenia

6

Australia
Austria

Category

Region (WHO)3

0.845 Very High

Americas

0.776 High

Europe

200

0.944 Very High

Western Pacific

254

0.922 Very High

Europe

Azerbaijan

2

0.756 High

Europe

Bahrain

1

0.852 Very High

Eastern Mediterranean

Bangladesh

1

0.632 Medium

South-East Asia

Barbados

1

0.814 Very High

Americas

Belarus

13

0.823 Very High

Europe

Belgium

335

0.931 Very High

Europe

88

Benin

2

0.545 Low

Bosnia and Herzegovina

8

0.78 High

Europe

Botswana

1

0.735 High

Africa

462

0.765 High

Americas

1

0.838 Very High

Western Pacific

21

0.816 Very High

Europe

0.452 Low

Africa

1102

0.929 Very High

Americas

Chile

51

0.851 Very High

Americas

China

1052

0.761 High

Western Pacific

Colombia

46

0.767 High

Americas

Croatia

32

0.851 Very High

Europe

Brazil
Brunei Darussalam
Bulgaria
Burkina Faso
Canada

1

Africa

Cuba

1

0.783 High

Americas

Cyprus

2

0.887 Very High

Europe

Czechia

148

0.9 Very High

Europe

Denmark

488

0.94 Very High

Europe

Dominican Republic

3

0.756 High

Americas

Ecuador

1

0.759 High

Americas

477

0.707 High

Eastern Mediterranean

0.892 Very High

Europe

0.485 Low

Africa

190

0.938 Very High

Europe

2

0.81755 Very High

France

794

0.901 Very High

Europe

Gabon

1

0.703 High

Africa

Georgia

3

0.812 Very High

Europe

675

0.947 Very High

Europe

0.611 Medium

Africa

0.888 Very High

Europe

Egypt
Estonia

21

Ethiopia

5

Finland
Former Serbia and
Montenegro

Germany
Ghana

3

Greece

128

Europe 4

89

Guam

2

0.9265 Very High

Guatemala

2

0.663 Medium

Americas

Equatorial Guinea

1

0.477 Low

Africa

Haiti

1

0.51 Low

Honduras

1

Western Pacific

Americas

0.634 Medium

Americas

59

0.949 Very High

Western Pacific

102

0.854 Very High

Europe

4

0.949 Very High

Europe

0.645 Medium

South-East Asia

Hong Kong, China
(SAR)
Hungary
Iceland
India

172

Indonesia

20

0.718 High

South-East Asia

Iran, Islamic Republic of

80

0.783 High

Eastern Mediterranean

0.674 Medium

Eastern Mediterranean

Iraq

9

Ireland

77

0.955 Very High

Europe

Israel

246

0.919 Very High

Europe

Italy

577

0.892 Very High

Europe

0.734 High

Americas

0.919 Very High

Western Pacific

Jamaica
Japan

1
127

Jordan

7

0.729 High

Eastern Mediterranean

Kazakhstan

1

0.825 Very High

Europe

Kenya

7

0.601 Medium

Africa

693

0.916 Very High

Western Pacific

Kuwait

3

0.806 Very High

Eastern Mediterranean

Latvia

21

0.866 Very High

Europe

Lebanon

21

0.744 High

Eastern Mediterranean

Lithuania

35

0.882 Very High

Europe

0.483 Low

Africa

Korea, Democratic
People’s Republic of

Malawi
Malaysia
Malta

4
50

0.81 Very High

1

0.895 Very High

Western Pacific
Europe
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Mauritania

1

0.546 Low

Africa
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0.779 High

Americas

Moldova, Republic of

1

0.75 High

Montenegro

3

0.829 Very High

Europe

Morocco

4

0.686 Medium

Eastern Mediterranean

Mozambique

1

0.456 Low

Africa

0.602 Medium

South-East Asia

Mexico

Nepal

12

Europe

Netherlands

416

0.944 Very High

Europe

New Zealand

68

0.931 Very High

Western Pacific

Niger

9

0.394 Low

Africa

Nigeria

8

0.539 Low

Africa

North Macedonia

1

0.774 High

Europe

257

0.957 Very High

Europe

Oman

51

0.813 Very High

Eastern Mediterranean

Pakistan

29

0.557 Medium

Eastern Mediterranean

Panama

8

0.815 Very High

Americas

Paraguay

1

0.728 High

Americas

Peru

20

0.777 High

Americas

Philippines

19

0.718 High

Western Pacific

Norway

Poland

220

0.88 Very High

Europe

Portugal

60

0.864 Very High

Europe

Puerto Rico

29

0.9265 Very High

Qatar

2

0.848 Very High

Réunion

1

0.9015 Very High

Africa 4

Romania

50

0.828 Very High

Europe

151

0.824 Very High

Europe

40

0.854 Very High

Eastern Mediterranean

0.512 Low

Africa

0.806 Very High

Europe

0.452 Low

Africa

Russian Federation
Saudi Arabia
Senegal
Serbia
Sierra Leone

1
35
1

Americas
Eastern Mediterranean
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Singapore

79

0.938 Very High

Slovakia

20

0.86 Very High

Europe

Slovenia

27

0.917 Very High

Europe

South Africa

61

0.709 High

Africa

0.904 Very High

Europe
South-East Asia

Spain

484

Sri Lanka

2

0.782 High

Sudan

1

0.51 Low

Western Pacific

Eastern Mediterranean

Sweden

395

0.945 Very High

Europe

Switzerland

295

0.955 Very High

Europe

0.567 Medium

Eastern Mediterranean

Syrian Arab Republic

7
189

0.7615 High

1

0.529 Low

Africa

155

0.777 High

South-East Asia

Republic of the

1

0.48 Low

Trinidad and Tobago

1

0.796 High

Tunisia

16

0.74 High

Eastern Mediterranean

Turkey

327

0.82 Very High

Europe

Uganda

15

0.544 Low

Africa

Ukraine

36

0.779 High

Europe

Taiwan

Western Pacific 4

Tanzania, United
Republic of
Thailand
Congo, The Democratic

United Arab Emirates
United Kingdom
United States

Africa
Americas

5

0.89 Very High

Eastern Mediterranean

604

0.932 Very High

Europe

4022

0.926 Very High

Americas

Venezuela

3

0.711 High

Americas

Viet Nam

6

0.704 High

Western Pacific

Zambia

1

0.584 Medium

Africa

Zimbabwe

2

0.571 Medium

Africa
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1. Country names were listed according to their United Nations 2019 name
accompanying their HDI value. If not present, they were named according to
their ClinicalTrials.gov reported name.
2. HDI values were obtained from the United Nations 2019 report.
3. HDI values were sorted into universally accepted HDI values as follows:
Low below 0.550, Medium from 0.550 to 0.699, High from 0.700 to 0.799,
and Very High from 0.800 to 1
4. Countries were assigned to regions according to the World Health
Organization definitions of world regions and belonging countries.
5. Countries were not listed in any regions according to the World Health
Organization, so they were placed in into regions based on their geographic
location.
6. Countries that did not have HDIs available in the United Nations 2019
report were matched with countries that they most currently or most recently
belonged to, or an average of various relevant countries. This includes Former
Serbia and Montenegro using the HDI of the average of present-day Serbia
and present-day Montenegro, Guam and Puerto Rico both being a territory of
the United States using its HDI, Réunion using the HDI of France having held
the status of a region in France and Taiwan using the HDI of the Republic of
China.
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Appendix 4: Surgical categories and the respective surgical procedures belonging to
those categories along with the frequencies
Category

Types of surgeries
breast (non-cosmetic), mastectomy, capsulectomy,

Breast Surgery

Frequency
380

lumpectomy,
Arthroplasty, foot, hip, knee, wrist, hand,

2745

arthroplasty, arthroscopy, tibia, ankle, femoral,
shoulder, orthopedic, elbow, spine, vertebroplasty,
bunionectomy, Achilles, rotator cuff, osteotomy,
joint, laminectomy, patellar, meniscectomy,
acromioplasty, clavicle, Ewing, corticotomy,
amputations, tenotomy, fasciotomy, tendon
ruptures, laminoplasty, discectomy, curettage,
Orthopedic Surgery

osteosarcoma, myotomy, acromioplasty
neurology, nerve, pituitary, brain, neurosurgery,

308

craniotomy, schwannoma, foraminotomy,
craniectomy, posterior fossa, rhizotomy,
Neurology

neurectomy, epilepsy, carcinologic,

Transplant

transplant

738

cesarean, cesarian, obgyn, hysterectomy,

1318

vaginectomy, oophorectomy, ovarian,
myomectomy, uterus, episiotomy,
Obstetrics and

sacrocolpopexy, endometriosis, endometrial

Gynecology

abortion, large loop excision, cervical, episiotomy
contour, plastic, reconstruction, augmentation,
reduction, cosmetic, panniculectomy,
abdominoplasty, rhytidoplasty, lipectomy,
mammoplasty, rhinoplasty, Mohs, burn, foot

Plastic

ulcer, scar, bichectomy

256
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bladder, urinary, prostatectomy, kidney,

713

nephrectomy, adrenalectomy, pelvic,
Urethroplasty, sling, adrenalectomy,
nephrolithotomy, prostate, vasectomy,
Urology

Varicocelectomy
Children, Pediatric, infant, prenatal, neonate,

Pediatric Surgery

482

neonatal,
Cardiac, lung, chest wall, valve, vessel, vein,

2198

artery, heart, cabg, coronary, pulmonary,
angioplasty, fontan, sternotomy, lobectomy,
thoracic, atherectomy, esophagectomy, esophagus,
thoracotomy, vascular, thromboendarterectomy,
pleurectomy, lymphadenectomy, lymph node,
Cardiac/Vascular/Thoracic Heller, sternum, sternotomy, rib, Mesothelioma,
Surgery

pleurectomy, bullectomy, segmentectomy
tympano, tonsillectomy, sinus, septoplasty, throat, 312
nose, sinonasal, adenotonsillectomy,
Laryngectomy, uvulopalatopharyngoplasty, ENT,
cleft, neck, adenotomy, septorhinoplasty,
dacryocystorhinostomy, parotidectomy,

Otolaryngology (ENT)

Laryngopharyngeal, vocal cord,
Thyroid, thyroidectomy

121

dental, molar, tooth, pulpotomy, gingivectomy,

443

Thyroid

dental implant, periodontal, orthognathic,
Dental, Oral and

mandibulectomy, maxillofacial, pulpotomy,

Maxillofacial Surgery

operculectomy, gingival
hemorrhoidectomy, anoplasty, colectomy, rectal, 754
colon, colorectal, colostomy, Rectopexy,
ileostomy, polypectomy, haemorrhoidectomy,

Colon and Rectal Surgery fistulectomy
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Ophthalmic, cataract, eye, trabeculoplasty,

583

opthalmic, vitrectomy, retinectomy, retinal,
intraocular lens, canaloplasty, Keratectomy,
trabeculectomy, pterygium, strabismus,
Ophthalmic Surgery

blepharoplasty, iridectomy
any, general, splenectomy, appendix,

471

umbilectomy, soft tissue, retroperitoneal,
General Surgery

periampullary
Gastrectomy, cholecystectomy, gastrectomy,

1939

fundoplication, bariatric, hernia, abdominal,
hernioplasty, gastric bypass, lichtenstein,
digestive, stomach, GI, pancreaticoduodenectomy,
pancreas, roux-en-y, splanchnicectomy,
pancreatectomy, omentectomy, hepatectomy,
liver, splanchnicectomy, hernioplasty, HCC,
Gastroenterology

papillectomy, crohn

Appendix 5: Details for Python program

A custom Python program was used to find the best-matched articles on PubMed and
PubMed Central based on the available information provided in the registrations on
ClinicalTrials.gov. This was done using 12 pieces of information from the individual
ClinicalTrials.gov registries to be searched on the PubMed platform and returning a list
of up to 3 of the most related published studies to the information from the registry.
This was returned using study PMID or PMCID number. As a result, the corresponding
articles from PMID or PMCID numbers were examined and compared against the
ClinicalTrials.gov registry to see if they are matching and can be considered the
published version of that registry.
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Appendix 6: Definitions of spin for assessing conclusion spin according to Boutron
et al.15

Reproduced with permission from [Journal of the American Medical Association.
2010. 303(20): doi:10.1001/jama.2010.651. Copyright©(2010) American Medical
Association. All rights reserved.

Appendix 7: Definitions and categorization of data extraction items
Category of Item extracted

Definition and Source

Extraction Notes

items
extracted
Other
relevant

Clinical Trials URL

The study related registration Extracted from
URL link on clinicaltrials.gov RCTa registration

information

pages on
Clinicaltrials.gov

Other
relevant
information

Published article URL The URL where the
published article was found

Extracted from
RCT registration
pages on
Clinicaltrials.gov
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Other

Title of Clinical Trials Title of the registered RCT

Extracted from

relevant

registration

RCT registration

information

pages on
Clinicaltrials.gov

Characteristic Status of the registry

Whether the study is still

Extracted from

enrolling, has been

RCT registration

terminated, withdrawn,

pages on

completed, etc.

Clinicaltrials.gov

Characteristic Condensed definition Condensed version of the

Re-categorizes the

of study status of the

status of the registry in order given status of the

registered RCT

to easily classify. Completed registry into our
status on clinicaltrials.gov

simplified list of

was categorized as

categories:

‘completed’. Status of

completed, not

suspended, terminated,

completed or on-

withdrawn, or unknown was going
reclassified as ‘not
completed’. Status of
recruiting, not yet recruiting,
active but not recruiting,
ongoing, or enrolling by
invitation was reclassified as
‘ongoing’
Characteristic Country

Country where the study was Extracted from
conducted

RCT registration
pages on
Clinicaltrials.gov.
If not found, then
extracted from any
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study-related
publication(s).
Characteristic HDIb number

HDI number associated with Matched with listed
the country where the study

countries using

was taking place.

United Nations
2019 report.23 If
more than one
country was
present, the
average was taken.

Characteristic HDI category

Low below 0.550, medium

Matched through

from 0.550 to 0.699, high

HDI number.

from 0.700 to 0.799, and very
high from 0.800 to 1
Other

Condition/disease

The disease, disorder,

Extracted from

relevant

syndrome, illness, or injury

RCT registration

information

that is being studied.c

pages on
Clinicaltrials.gov

Other

Interventions/treatment A process of action that is the Extracted from

relevant

focus of a clinical study,

information

typically a surgical procedure pages on
+/- other intervention for

RCT registration

Clinicaltrials.gov

registered included RCTs. c
Other

Arm

A group of participants in a

Extracted from

relevant

clinical trial that receives a

RCT registration

information

specific intervention/treatment pages on
or no intervention according

Clinicaltrials.gov

to the trial’s protocol. c
Other

Surgical specialty

The category of surgery that Extracted from

relevant

the type of surgery in the

RCT registration

information

study belongs to. This was

pages on

99

divided into 16 categories

Clinicaltrials.gov,

known as breast, orthopedic, matched with one
neurology, transplant,

of these 16

obstetrics and gynecology,

categories after

plastic, urology, pediatric,

analyzing the

cardiac, vascular, and

condition,

thoracic, otolaryngology,

interventions and

thyroid, dental, oral and

arms.

maxillofacial, colon and
rectal, ophthalmic,
gastroenterology and general.
Necessary

Primary outcome

The primary outcomes that

Extracted from

information intended (POI d)

were intended to be reported RCT registration

for further

on, based on the RCT

pages on

decisions

registration. This was

Clinicaltrials.gov

repeated for the first 5 POI.
Necessary

POI positive or

If the POI was significant it

Obtained from

information negative

was labelled “positive”, and

publication

for further

non-significant was labelled

decisions

”negative”. Alternatively, if
significance was not clear it
was assumed based on the
language used. This was
repeated for the first 5 POI.

Necessary

POI effect measure

The effect measure and

Obtained from

information

outcome used to measure the publication

for further

POI was listed. This was

decisions

repeated for the first 5 POI.

Necessary

POI p-

information value/significance

Preferably the p-value was

Obtained from

listed here to suggest the

publication

significance. If it was not
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for further

available, the method used to

decisions

address significance was
listed such as confidence
intervals, language or
indication of significance.
This was repeated for the first
5 POI.

Necessary

Primary outcome

information reported (POR e)

The primary outcomes that

Obtained from

the study actually reported on. publication for up

for further

to 5 primary
If the primary outcomes (PO ) outcomes. If POI
were not explicitly stated in was not explicitly
f

decisions

the registry, the PO were

stated, the first

extracted from the publication results-based
of the study. This was

outcomes listed

repeated for the first 5 POI.
Necessary

POR positive or

If the POR was significant it Obtained from

information negative

was labelled “positive”, and

for further

non-significant was labelled

decisions

”negative”. Alternatively, if

publication

significance was not clear it
was assumed based on the
language used. This was
repeated for the first 5 POI.
Necessary

POR effect measure

The effect measure and

Obtained from

information

outcome used to measure the publication

for further

POR was listed. This was

decisions

repeated for the first 5 POI.
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Necessary

POR p-

Preferably the p-value was

Obtained from

information value/significance

listed here to suggest the

publication

for further

significance. If it was not

decisions

available, the method used to
address significance was
listed such as confidence
intervals, language or
indication of significance.
This was repeated for the first
5 POI.

Necessary

Secondary/Other

The secondary outcomes that Extracted from

information outcomes Intended

were intended to be reported RCT registration

for further

on, based on the registry.

decisions
Necessary

pages on
Clinicaltrials.gov

Secondary/Other

The secondary outcomes that Obtained from

information outcomes Reported

were actually reported on.

for further

Only the outcomes were

decisions

obtained, without mention of

publication

significance.
Distortion

Are POI adequately

Answered “yes” if the

Reported after

category

defined?

outcome has an unequivocal

analyzing the POI

description with a method of from the registry
measurement (if applicable),
and a specified time frame.6
Distortion

Are POR clinically

Answered “yes” if the

Reported after

category

relevant?

outcome was relating to

analyzing all of the

mortality, disability/functional POR
status (e.g., ability to walk),
disease/serious morbidity or
discomfort (e.g., quality of
life, pain).
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Distortion

Were the outcomes the Answered “no” if any of the

Reported after

category

same as planned?

outcomes differed from the

analyzing the

registry outcomes and were

intended outcomes

not the same as planned

compared to the

(primary or secondary).

reported

Distortion

Were non-significant Answered “yes” if any

category

POI demoted?

Reported after

intended non-significant POI analyzing the PO
were demoted from a primary intended and
outcome.

reported

Distortion

Were POI not reported Answered “yes” if any POI

Reported after

category

at all?

were not at all present in the

analyzing the PO

study.

intended and
reported

Distortion

Were the PO the same, Answered “yes” if the

category

but with different time intended and reported primary analyzing the PO
frames?

Reported after

outcomes were the same but

intended and

had different time frames.

reported

Answered “yes” if the

Reported after

Distortion

Were significant

category

outcomes promoted to significant outcomes were

analyzing the PO

POR?

intended and

added to the POR, but they

weren’t mentioned as a POI. reported
Necessary

Overall POI

Overall significance of POI

Extracted from trial

information significance?

was reported in 6 classes as

publication

for further

either significant (all of the

decisions

outcomes were significant),
mostly significant (if more
than half of the outcomes
were significant), mixed (if
exactly half of the outcomes
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were significant), mostly nonsignificant (more than half of
the outcomes were nonsignificant), non-significant
(all the outcomes were nonsignificant) or unknown if the
outcomes were not reported at
all.
Necessary

Overall POR

Overall significance of POR Extracted from the

information significance?

was reported in 6 classes as

for further

either significant (all of the

decisions

outcomes were significant),

trial publication

mostly significant (if more
than half of the outcomes
were significant), mixed (if
exactly half of the outcomes
were significant), mostly nonsignificant (more than half of
the outcomes were nonsignificant), non-significant
(all the outcomes were nonsignificant) or unknown if the
outcomes were not reported at
all.
Distortion

Did the results “turn

Answered “yes” if the POI

category

positive” due to

overall significance was more analyzing the

outcome distortion?

significant in the hierarchy

overall POI

than the POI overall

significance and

significance. Also noted as

the overall POR

“yes” was if the POI was

significance.

unknown due to being omitted

Reported after
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from the study, and the POR Extracted from the

Necessary

Was the abstract

was reported positive.

trial publication.

If the abstract conclusion

Obtained from

information conclusion positive or claimed an overall difference publication
for further

negative?

decisions
Necessary

between interventions, then it
was considered positive.

Quote from the

information abstract conclusion

Direct quote of the abstract

Obtained from

conclusion.

publication

If the discussion conclusion

Obtained from

for further
decisions
Necessary

Was the discussion

information conclusion positive or claimed an overall difference publication
for further

negative?

decisions
Necessary

between interventions, then it
was considered positive.

Quote from the

Direct quote of the discussion Obtained from

information discussion conclusion conclusion.

publication

for further
decisions
Distortion

Was either conclusion Answered “yes” if the abstract Reported after

category

different from the POR conclusion was more

analyzing the

to make the overall

overall POR

significant in the hierarchy

result “turn positive”? than the POR conclusion.

significance
compared to the
conclusion
significance.
Extracted from the
trial publication.
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Necessary

Was there spin in the Answered “yes” if there was Reported after

information conclusion?

any conclusion spin in either analyzing the

for further

of the conclusions (see

conclusion quotes

decisions

Appendix 3.1 for details).

based on selected
criteria15

Necessary

Quote of spin in the

information conclusion

Direct quote of where the

Obtained from

conclusion spin was seen.

publication

for further
decisions
Distortion

Level of conclusion

The level of the conclusion

Reported after

category

spin (0-3)

spin indication, decided by

analyzing the

predefined criteria and

conclusion quotes

separated into any, low,

based on selected

medium, high, or none.10

criteria from the
literature.15

General

Overall suspicion of

Overall judgement for general Reported

Distortion

distortion

suspicion of distortion within subjectively after

category

the publication labelled as

reading publication

low, medium, high, or none.

and analyzing the
POI, POR and
conclusions

Other

Comments

Any comments for

Reported after data

relevant

justifications of any extracted extraction was

information

points, or explanations that

complete if

were thought necessary to

necessary

include.
Characteristic Enrollment size from The enrollment size that was
Clinical Trials

Extracted from

obtained for the study. The

RCT registration

most recent enrollment size

pages on

was used.

Clinicaltrials.gov
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Characteristic Actual enrollment size The actual enrollment size
reported in the publication

Obtained from
publication

that was used for the study. If
multiple were offered, the
number of subjects
randomized was used.
Characteristic Start date

The date on which the registry Extracted from
was first available on

RCT registration

ClinicalTrials.gov.

pages on
Clinicaltrials.gov

Characteristic Date of publication

The date of which the

Obtained from

publication was successfully publication
published.
Characteristic Time to publication

The time between the date of Calculated by

- Impact

registration to the date of

subtracting start

publication for a study.

date of RCT

(months)

registration on
Clinicaltrials.gov
from date of RCT
publication
reported on journal
URL
Characteristic Number of citations

The number of citations

Obtained by

- Impact

received by the study.

searching the
article in Google
Scholar

Characteristic Journal

The journal where the study

Obtained from

- Impact

was published.

publication
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Characteristic Journal Impact Factor Journal impact factor (JIF g) of Obtained from a
- Impact

the journal of publication in

journal citation

the year of publication. For

report (Clarivate).27

studies published in 2021, the
JIF for the year 2020 was
used. If journals or the year of
the journal was not available
in the journal citation report,
it was labelled “not
available”.
General

Number of times

The number of times an

Distortion

distortion occurred

incident of distortion occurred summing each time

category

Calculated by

either in the outcomes or in

a “category of

the conclusion, labelled as

distortion” was

“distortion category” in this

deemed

table.

unfavourable

a.

RCT= Randomized controlled trial

b.

HDI= Human development index

c.

Definition taken from ClinicalTrials.gov

d.

POI=Primary outcome intended

e.

POR=Primary outcome reported

f.

PO=Primary outcome

g.

JIF=Journal Impact Factor
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